| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 MASP1 MYO5A CDHR1 CDHR3 ADGRV1 DYSF FSCB S100A1 FAT1 PLCB1 NID1 PLCB3 PLCD1 PLS3 SELL PLCZ1 S100A16 ANXA3 PCDHB11 PCDHB8 PKD2L1 PCDHA5 CLSTN1 SLC25A12 MCTP1 PKD2L2 VCAN PCDHGB4 CDH6 CDH9 CDH13 | 8.02e-07 | 749 | 327 | 32 | GO:0005509 |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF21B DHX36 ATP6V1B2 MYO5A ZGRF1 KIF1B DDX42 DNAH14 KIF9 ATP2C2 DDX54 SHPRH DNAH6 DNAH8 MRE11 DYNC2H1 UPF1 DMC1 TRAP1 ATAD3B ABCA5 SLFN13 AACS ERCC6L2 SMARCA2 UBA6 TOP2A SMC1B | 1.15e-06 | 614 | 327 | 28 | GO:0140657 |
| GeneOntologyMolecularFunction | glycogen phosphorylase activity | 4.35e-06 | 3 | 327 | 3 | GO:0008184 | |
| GeneOntologyMolecularFunction | sodium channel activity | 2.11e-05 | 52 | 327 | 7 | GO:0005272 | |
| GeneOntologyMolecularFunction | 1,4-alpha-oligoglucan phosphorylase activity | 4.25e-05 | 5 | 327 | 3 | GO:0004645 | |
| GeneOntologyMolecularFunction | phosphatidylinositol phospholipase C activity | 5.66e-05 | 26 | 327 | 5 | GO:0004435 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 5.66e-05 | 26 | 327 | 5 | GO:0005248 | |
| GeneOntologyMolecularFunction | sodium ion binding | 6.21e-05 | 14 | 327 | 4 | GO:0031402 | |
| GeneOntologyMolecularFunction | phospholipase C activity | 9.82e-05 | 29 | 327 | 5 | GO:0004629 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.47e-04 | 70 | 327 | 7 | GO:0003777 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.80e-04 | 18 | 327 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 2.48e-04 | 127 | 327 | 9 | GO:0008094 | |
| GeneOntologyMolecularFunction | pyridoxal phosphate binding | 3.00e-04 | 56 | 327 | 6 | GO:0030170 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 3.24e-04 | 37 | 327 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | vitamin B6 binding | 3.31e-04 | 57 | 327 | 6 | GO:0070279 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | KIF21B DHX36 KIF1B LRRK2 DDX42 TUFM RAB8A KIF9 RAB24 ATP2C2 DDX54 RAB7A DNAH6 DNAH8 RAB5A RAB13 DYNC2H1 UPF1 DMC1 TRAP1 ATAD3B RGS6 ABCA5 SLFN13 RAB21 SMC1B | 4.64e-04 | 775 | 327 | 26 | GO:0017111 |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | ASIC2 SLC9C1 SLC13A4 SCN1A SCN2A SCN3A SCN8A PKD2L1 GRIA2 CNNM4 | 5.33e-04 | 171 | 327 | 10 | GO:0015081 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | KIF21B DHX36 KIF1B LRRK2 DDX42 TUFM RAB8A KIF9 RAB24 ATP2C2 DDX54 RAB7A DNAH6 DNAH8 RAB5A RAB13 DYNC2H1 UPF1 DMC1 TRAP1 ATAD3B RGS6 ABCA5 SLFN13 ASMTL RAB21 SMC1B | 6.81e-04 | 839 | 327 | 27 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | KIF21B DHX36 KIF1B LRRK2 DDX42 TUFM RAB8A KIF9 RAB24 ATP2C2 DDX54 RAB7A DNAH6 DNAH8 RAB5A RAB13 DYNC2H1 UPF1 DMC1 TRAP1 ATAD3B RGS6 ABCA5 SLFN13 ASMTL RAB21 SMC1B | 6.94e-04 | 840 | 327 | 27 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | KIF21B DHX36 KIF1B LRRK2 DDX42 TUFM RAB8A KIF9 RAB24 ATP2C2 DDX54 RAB7A DNAH6 DNAH8 RAB5A RAB13 DYNC2H1 UPF1 DMC1 TRAP1 ATAD3B RGS6 ABCA5 SLFN13 ASMTL RAB21 SMC1B | 6.94e-04 | 840 | 327 | 27 | GO:0016818 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 7.30e-04 | 118 | 327 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | natriuretic peptide receptor activity | 7.93e-04 | 3 | 327 | 2 | GO:0016941 | |
| GeneOntologyMolecularFunction | alkali metal ion binding | 7.94e-04 | 26 | 327 | 4 | GO:0031420 | |
| GeneOntologyMolecularFunction | small GTPase binding | MYO5A SYTL2 LRRK2 RAB8A DENND1B RAB7A DENND5B MAPKAP1 WHAMM CYFIP2 INF2 PAK2 TNFAIP1 SORL1 | 8.87e-04 | 321 | 327 | 14 | GO:0031267 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF21B DHX36 KIF1B DDX42 KIF9 ATP2C2 DDX54 DNAH6 DNAH8 DYNC2H1 UPF1 DMC1 TRAP1 ATAD3B ABCA5 SLFN13 SMC1B | 1.03e-03 | 441 | 327 | 17 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 1.06e-03 | 28 | 327 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | phosphoric diester hydrolase activity | 1.08e-03 | 97 | 327 | 7 | GO:0008081 | |
| GeneOntologyMolecularFunction | calcium-dependent protein binding | 1.15e-03 | 98 | 327 | 7 | GO:0048306 | |
| GeneOntologyMolecularFunction | helicase activity | 1.21e-03 | 158 | 327 | 9 | GO:0004386 | |
| GeneOntologyMolecularFunction | vitamin binding | 1.38e-03 | 161 | 327 | 9 | GO:0019842 | |
| GeneOntologyBiologicalProcess | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules | 1.71e-06 | 53 | 326 | 8 | GO:0016339 | |
| GeneOntologyBiologicalProcess | Golgi vesicle transport | MON2 MYO5A VPS13C COPB2 LRRK2 RAB8A MIA2 PLCB3 CTAGE4 RAB13 CTAGE9 COG2 WHAMM CTAGE6 CTAGE8 CTAGE15 HTT SORL1 | 8.40e-06 | 339 | 326 | 18 | GO:0048193 |
| GeneOntologyBiologicalProcess | vesicle cargo loading | 1.94e-05 | 36 | 326 | 6 | GO:0035459 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | DLGAP1 PDE4A TRIO MYO5A LRRK2 HMGCR DYSF SLC7A11 RAB8A JAK2 UBE3A PLCB1 PLCL1 NOS1 RAB5A HTR1B LAMA2 GRIA2 SPG11 CLSTN1 GRM6 MCTP1 P2RX3 VPS35 HTT EPHA7 | 2.16e-05 | 663 | 326 | 26 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | DLGAP1 PDE4A TRIO MYO5A LRRK2 HMGCR DYSF SLC7A11 RAB8A JAK2 UBE3A PLCB1 PLCL1 NOS1 RAB5A HTR1B LAMA2 GRIA2 SPG11 CLSTN1 GRM6 MCTP1 P2RX3 VPS35 HTT EPHA7 | 2.22e-05 | 664 | 326 | 26 | GO:0099177 |
| GeneOntologyBiologicalProcess | establishment of protein localization to extracellular region | MYO5A HMGCR RAB8A JAK2 BMP6 MIA2 AFM PLCB1 CTAGE4 NOS1 RAB13 CTAGE9 CTAGE6 PPARG LEPR FRMD4A VPS35 CTAGE8 AACS CTAGE15 HTT | 3.13e-05 | 483 | 326 | 21 | GO:0035592 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | DLGAP1 PDE4A TRIO MYO5A ASIC2 KIF1B LRRK2 HMGCR DYSF SLC7A11 RAB8A JAK2 PTCHD1 UBE3A PLCB1 PLCL1 NOS1 RAB5A NPR2 HTR1B PCDHB11 PCDHB8 LAMA2 GRIA2 SPG11 CLSTN1 GRM6 MCTP1 P2RX3 VPS35 HTT EPHA7 | 3.35e-05 | 931 | 326 | 32 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | DLGAP1 PDE4A TRIO MYO5A ASIC2 KIF1B LRRK2 HMGCR DYSF SLC7A11 RAB8A JAK2 PTCHD1 UBE3A PLCB1 PLCL1 NOS1 RAB5A NPR2 HTR1B PCDHB11 PCDHB8 LAMA2 GRIA2 SPG11 CLSTN1 GRM6 MCTP1 P2RX3 VPS35 HTT EPHA7 | 3.35e-05 | 931 | 326 | 32 | GO:0007268 |
| GeneOntologyBiologicalProcess | synaptic signaling | DLGAP1 PDE4A TRIO MYO5A ASIC2 KIF1B LRRK2 HMGCR DYSF SLC7A11 RAB8A JAK2 PTCHD1 UBE3A PLCB1 PLCL1 NOS1 UTRN RAB5A NPR2 HTR1B PCDHB11 PCDHB8 LAMA2 GRIA2 SPG11 CLSTN1 GRM6 MCTP1 P2RX3 VPS35 HTT EPHA7 | 3.47e-05 | 976 | 326 | 33 | GO:0099536 |
| GeneOntologyBiologicalProcess | protein localization to extracellular region | MYO5A HMGCR RAB8A JAK2 BMP6 MIA2 AFM PLCB1 CTAGE4 NOS1 RAB13 CTAGE9 CTAGE6 PPARG LEPR FRMD4A VPS35 CTAGE8 AACS CTAGE15 HTT | 3.85e-05 | 490 | 326 | 21 | GO:0071692 |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | DLGAP1 PDE4A TRIO MYO5A ASIC2 KIF1B LRRK2 HMGCR DYSF SLC7A11 RAB8A JAK2 PTCHD1 UBE3A PLCB1 PLCL1 NOS1 RAB5A NPR2 HTR1B PCDHB11 PCDHB8 LAMA2 GRIA2 SPG11 CLSTN1 GRM6 MCTP1 P2RX3 VPS35 HTT EPHA7 | 3.95e-05 | 939 | 326 | 32 | GO:0099537 |
| GeneOntologyBiologicalProcess | cellular catabolic process | HEXA ATP6V1B2 CYP4F8 MYO5A INPP4A VPS13C LRRK2 ALDH1L1 CYP39A1 RAB8A GGT7 LPIN1 NLN RAB24 TGFBRAP1 PLCB1 RAB7A PLCB3 XYLB NOS1 RAB5A WDR24 PDCD6IP ANPEP PRDX4 SHMT1 PON3 SPG11 LEPR TRIM5 EPG5 GSTM1 NAMPT THOP1 VPS35 KDM4A CERS1 HTT SORL1 | 4.15e-05 | 1253 | 326 | 39 | GO:0044248 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 CDHR1 CDHR3 FAT1 PCDHB11 PCDHB8 PCDHA5 CLSTN1 PCDHGB4 CDH6 CDH9 CDH13 | 4.49e-05 | 187 | 326 | 12 | GO:0007156 |
| GeneOntologyBiologicalProcess | endoplasmic reticulum to Golgi vesicle-mediated transport | COPB2 LRRK2 MIA2 CTAGE4 CTAGE9 WHAMM CTAGE6 CTAGE8 CTAGE15 HTT SORL1 | 4.70e-05 | 159 | 326 | 11 | GO:0006888 |
| GeneOntologyBiologicalProcess | adherens junction organization | 4.85e-05 | 61 | 326 | 7 | GO:0034332 | |
| GeneOntologyBiologicalProcess | protein secretion | MYO5A HMGCR RAB8A JAK2 BMP6 MIA2 PLCB1 CTAGE4 NOS1 RAB13 CTAGE9 CTAGE6 PPARG LEPR FRMD4A VPS35 CTAGE8 AACS CTAGE15 HTT | 8.65e-05 | 480 | 326 | 20 | GO:0009306 |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | CYP4F8 MYO5A INPP4A INPPL1 DHDDS HMGCR DYSF CYP39A1 SLC7A11 BMP6 FDFT1 PLCB1 PLCB3 PLCD1 PPIP5K2 ALDH3A2 PSAT1 NPR1 LEPR SLC25A12 ABCA5 VPS35 EPAS1 HTT | 9.23e-05 | 641 | 326 | 24 | GO:1901615 |
| GeneOntologyBiologicalProcess | response to nitrogen compound | DHX36 MYO5A VPS13C INPPL1 UGGT1 LRRK2 GDF10 RAB8A TXN JAK2 LPIN1 FAT1 UBE3A PLCB1 PYGM TIMELESS MTARC2 PLCD1 NNMT NOS1 RAB13 SELL NPR2 HTR1B SHMT1 GRIA2 PPARG EPG5 GSTM1 NAMPT P2RX3 VPS35 AACS MTR CDH13 HTT SORL1 SOS2 | 1.23e-04 | 1272 | 326 | 38 | GO:1901698 |
| GeneOntologyBiologicalProcess | inositol trisphosphate metabolic process | 1.24e-04 | 17 | 326 | 4 | GO:0032957 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | ASIC2 SLC9C1 SLC13A4 SCN1A SCN2A SCN3A SCN8A PLCB1 NOS1 UTRN PKD2L1 CNNM4 | 1.24e-04 | 208 | 326 | 12 | GO:0035725 |
| GeneOntologyBiologicalProcess | inositol phosphate metabolic process | 1.64e-04 | 52 | 326 | 6 | GO:0043647 | |
| GeneOntologyBiologicalProcess | regulation of mitotic DNA damage checkpoint | 2.49e-04 | 2 | 326 | 2 | GO:1904289 | |
| GeneOntologyBiologicalProcess | negative regulation of vacuolar transport | 2.49e-04 | 2 | 326 | 2 | GO:1903336 | |
| GeneOntologyBiologicalProcess | negative regulation of late endosome to lysosome transport | 2.49e-04 | 2 | 326 | 2 | GO:1902823 | |
| GeneOntologyCellularComponent | endoplasmic reticulum exit site | 2.33e-07 | 42 | 325 | 8 | GO:0070971 | |
| GeneOntologyCellularComponent | glutamatergic synapse | KIF21B DLGAP1 DLG5 TRIO MYO5A INPP4A LRRK2 STK38 PDE10A RAB8A JAK2 UBE3A SCN2A MIB1 SCN8A PLCB1 RAB7A SIPA1L2 NOS1 RAB5A SLC2A14 GRIA2 CLSTN1 PPP2R1A VPS35 PAK2 ELAVL1 CDH6 CDH9 TMEM240 HTT EPHA7 | 1.71e-06 | 817 | 325 | 32 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | KIF21B DLGAP1 DLG5 ATR TRIO MYO5A ASIC2 INPP4A KIF1B LRRK2 RAB8A JAK2 UBE3A MIB1 SCN8A PLCB1 PLCB3 NOS1 UTRN RAB5A PCDHB8 LAMA2 GRIA2 CLSTN1 GRM6 P2RX3 VPS35 PAK2 ELAVL1 CDH9 TMEM240 HTT EPHA7 | 5.72e-05 | 1018 | 325 | 33 | GO:0098794 |
| GeneOntologyCellularComponent | site of DNA damage | ATR ZGRF1 STK38 TIMELESS OARD1 MRE11 MMS22L WDR70 DMC1 SLFN13 | 5.77e-05 | 137 | 325 | 10 | GO:0090734 |
| GeneOntologyCellularComponent | dendrite | DAB2IP KIF21B DHX36 MYO5A ASIC2 KIF1B SARM1 LRRK2 LMTK3 RAB8A TXN SACS SCN8A NOS1 RAB5A DIP2B HTR1B ANXA3 LAMA2 GRIA2 SPG11 CLSTN1 GRM6 CNNM4 PPP2R1A P2RX3 CDH9 HTT EPHA7 | 7.98e-05 | 858 | 325 | 29 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | DAB2IP KIF21B DHX36 MYO5A ASIC2 KIF1B SARM1 LRRK2 LMTK3 RAB8A TXN SACS SCN8A NOS1 RAB5A DIP2B HTR1B ANXA3 LAMA2 GRIA2 SPG11 CLSTN1 GRM6 CNNM4 PPP2R1A P2RX3 CDH9 HTT EPHA7 | 8.31e-05 | 860 | 325 | 29 | GO:0097447 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 1.16e-04 | 17 | 325 | 4 | GO:0001518 | |
| GeneOntologyCellularComponent | axon | DAB2IP KIF21B DHX36 MYO5A CDHR3 KIF1B SARM1 LRRK2 LMTK3 TXN SACS SCN1A SCN2A SCN3A SCN8A PYGB USH2A NOS1 RAB5A FBXW11 DIP2B HTR1B ANXA3 GRIA2 SPG11 P2RX3 RAB21 CDH9 HTT | 1.53e-04 | 891 | 325 | 29 | GO:0030424 |
| GeneOntologyCellularComponent | exocytic vesicle | ATP6V1B2 ATR MYO5A KIF1B SYTL2 LRRK2 DYSF RAB8A UBE3A RAB7A RAB5A RAB13 SLC2A14 GRIA2 MCTP1 | 1.59e-04 | 320 | 325 | 15 | GO:0070382 |
| GeneOntologyCellularComponent | somatodendritic compartment | DAB2IP KIF21B DHX36 MYO5A ASIC2 KIF1B SARM1 LRRK2 LMTK3 PDE10A RAB8A TXN SACS SCN1A SCN3A SCN8A USH2A NOS1 RAB5A FBXW11 DIP2B HTR1B ANXA3 LAMA2 GRIA2 SPG11 CLSTN1 GRM6 CNNM4 PPP2R1A P2RX3 VPS35 CDH9 HTT EPHA7 SORL1 | 1.96e-04 | 1228 | 325 | 36 | GO:0036477 |
| GeneOntologyCellularComponent | synaptic vesicle | ATP6V1B2 ATR MYO5A KIF1B LRRK2 DYSF RAB8A UBE3A RAB7A RAB5A RAB13 SLC2A14 GRIA2 MCTP1 | 2.73e-04 | 300 | 325 | 14 | GO:0008021 |
| GeneOntologyCellularComponent | melanosome | 3.90e-04 | 113 | 325 | 8 | GO:0042470 | |
| GeneOntologyCellularComponent | pigment granule | 3.90e-04 | 113 | 325 | 8 | GO:0048770 | |
| GeneOntologyCellularComponent | exocytic vesicle membrane | ATP6V1B2 ATR KIF1B LRRK2 DYSF RAB7A RAB5A SLC2A14 GRIA2 MCTP1 | 5.12e-04 | 179 | 325 | 10 | GO:0099501 |
| GeneOntologyCellularComponent | synaptic vesicle membrane | ATP6V1B2 ATR KIF1B LRRK2 DYSF RAB7A RAB5A SLC2A14 GRIA2 MCTP1 | 5.12e-04 | 179 | 325 | 10 | GO:0030672 |
| GeneOntologyCellularComponent | t-UTP complex | 7.16e-04 | 3 | 325 | 2 | GO:0034455 | |
| GeneOntologyCellularComponent | sarcolemma | 8.12e-04 | 190 | 325 | 10 | GO:0042383 | |
| GeneOntologyCellularComponent | sodium channel complex | 1.00e-03 | 29 | 325 | 4 | GO:0034706 | |
| GeneOntologyCellularComponent | site of double-strand break | 1.02e-03 | 101 | 325 | 7 | GO:0035861 | |
| GeneOntologyCellularComponent | secretory vesicle | HEXA ATP6V1B2 SPAM1 ATR MYO5A VPS13C KIF1B SYTL2 LRRK2 CD109 RCBTB2 DYSF RAB8A RAB24 UBE3A RAB7A PYGB AP1M1 PYGL BIN2 NOS1 RAB5A DNASE1L1 RAB13 SELL ANPEP ANXA3 PRDX4 SLC2A14 GRIA2 ATAD3B MCTP1 SPACA1 PAK2 | 1.05e-03 | 1246 | 325 | 34 | GO:0099503 |
| GeneOntologyCellularComponent | transport vesicle | ATP6V1B2 ATR MYO5A KIF1B SYTL2 COPB2 LRRK2 DYSF RAB8A UBE3A RAB7A AP1M1 RAB5A RAB13 SLC2A14 GRIA2 MCTP1 SORL1 | 1.37e-03 | 519 | 325 | 18 | GO:0030133 |
| GeneOntologyCellularComponent | cytoplasmic side of early endosome membrane | 1.42e-03 | 4 | 325 | 2 | GO:0098559 | |
| GeneOntologyCellularComponent | USH2 complex | 1.42e-03 | 4 | 325 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | FACT complex | 1.42e-03 | 4 | 325 | 2 | GO:0035101 | |
| GeneOntologyCellularComponent | catenin complex | 1.46e-03 | 32 | 325 | 4 | GO:0016342 | |
| GeneOntologyCellularComponent | presynapse | ATP6V1B2 ATR TRIO MYO5A CDHR3 KIF1B LRRK2 DYSF RAB8A UBE3A SCN1A SCN2A SCN8A RAB7A USH2A NOS1 RAB5A RAB13 HTR1B SLC2A14 GRIA2 MCTP1 P2RX3 VPS35 CDH9 HTT | 1.52e-03 | 886 | 325 | 26 | GO:0098793 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | PDE4A GALNT1 ADGRV1 FAT1 KLHL7 ATXN2 ATP2C2 KCNS2 NOS1 RAB5A BANK1 MRE11 PLCZ1 SH3RF1 S100A16 OAS2 UPF1 PPARG CYFIP2 EPG5 INF2 VPS35 PAK2 CRBN CDH13 HTT SORL1 | 1.54e-03 | 934 | 325 | 27 | GO:0048471 |
| GeneOntologyCellularComponent | transport vesicle membrane | ATP6V1B2 ATR KIF1B LRRK2 DYSF RAB7A AP1M1 RAB5A SLC2A14 GRIA2 MCTP1 SORL1 | 2.23e-03 | 293 | 325 | 12 | GO:0030658 |
| HumanPheno | Highly elevated creatine kinase | 3.94e-06 | 11 | 129 | 5 | HP:0030234 | |
| HumanPheno | Gaze-evoked nystagmus | 7.69e-06 | 55 | 129 | 9 | HP:0000640 | |
| HumanPheno | Proximal muscle weakness in lower limbs | KIF1B MAP3K20 HMGCR NEB DYSF SACS ATXN2 RAB7A COL6A3 COL12A1 LAMA2 PON3 CRPPA SPG11 MLIP INF2 | 1.49e-05 | 186 | 129 | 16 | HP:0008994 |
| HumanPheno | Bradykinesia | VPS13C LRRK2 UBAP1 DHDDS ADGRV1 NEB MYORG ATXN2 SCN1A SCN2A VPS35 HTT | 3.05e-05 | 116 | 129 | 12 | HP:0002067 |
| HumanPheno | Progressive proximal muscle weakness | 4.49e-05 | 27 | 129 | 6 | HP:0009073 | |
| HumanPheno | Gait disturbance | ATP6V1B2 TRIO VPS13C KIF1B COPB2 LRRK2 MAP3K20 OBSCN UBAP1 DHDDS HMGCR PDE10A NEB BCOR DYSF LPIN1 SAMD9L SACS ATXN2 UBE3A SCN1A SCN2A SCN3A SCN8A PLCB1 RAB7A KATNIP CUL4B DPH1 MRE11 COL6A3 COL12A1 DYNC2H1 B3GALNT2 ARX LAMA2 PON3 CRPPA GRIA2 SPG11 TSEN54 LMNB2 INTS8 CYFIP2 PPP2R1A INF2 VPS35 SYT14 SMARCA2 MTR RERE CERS1 TMEM240 HTT TCTN2 | 4.90e-05 | 1356 | 129 | 55 | HP:0001288 |
| HumanPheno | Abnormal calf musculature morphology | 6.40e-05 | 71 | 129 | 9 | HP:0001430 | |
| HumanPheno | Increased endomysial connective tissue | 1.24e-04 | 32 | 129 | 6 | HP:0100297 | |
| HumanPheno | Abnormal muscle fiber protein expression | 1.24e-04 | 32 | 129 | 6 | HP:0030089 | |
| HumanPheno | Muscle spasm | VPS13C LRRK2 MAP3K20 OBSCN UBAP1 LPIN1 ATXN2 PYGL PYGM LAMA2 PON3 CRPPA MLIP VPS35 | 1.40e-04 | 178 | 129 | 14 | HP:0003394 |
| HumanPheno | Abnormality of the musculature of the lower limbs | KIF1B MAP3K20 HMGCR NEB DYSF SACS ATXN2 RAB7A CUL4B COL6A3 COL12A1 LAMA2 PON3 CRPPA SPG11 TSEN54 PPARG MLIP INF2 | 1.45e-04 | 297 | 129 | 19 | HP:0001437 |
| MousePheno | enlarged stomach | ANKRD20A3P ANKRD20A8P ANKRD18B ANKRD20A4P ANKRD18A NOS1 ANKRD20A1 PDCD6IP | 2.23e-07 | 33 | 282 | 8 | MP:0003883 |
| MousePheno | abnormal nervous system electrophysiology | ASIC2 LRRK2 PDE10A LPIN1 PTCHD1 UBE3A SCN1A SCN2A KCNJ16 SCN8A PLCL1 NOS1 ARX SLC2A14 LAMA2 PKD2L1 GRIA2 LEPR P2RX3 SUPT16H | 1.19e-05 | 329 | 282 | 20 | MP:0002272 |
| Domain | CADHERIN_1 | DCHS2 CDHR1 CDHR3 FAT1 PCDHB11 PCDHB8 PCDHA5 CLSTN1 PCDHGB4 CDH6 CDH9 CDH13 | 5.67e-07 | 113 | 321 | 12 | PS00232 |
| Domain | Cadherin | DCHS2 CDHR1 CDHR3 FAT1 PCDHB11 PCDHB8 PCDHA5 CLSTN1 PCDHGB4 CDH6 CDH9 CDH13 | 5.67e-07 | 113 | 321 | 12 | PF00028 |
| Domain | - | DCHS2 CDHR1 CDHR3 FAT1 PCDHB11 PCDHB8 PCDHA5 CLSTN1 PCDHGB4 CDH6 CDH9 CDH13 | 6.24e-07 | 114 | 321 | 12 | 2.60.40.60 |
| Domain | CADHERIN_2 | DCHS2 CDHR1 CDHR3 FAT1 PCDHB11 PCDHB8 PCDHA5 CLSTN1 PCDHGB4 CDH6 CDH9 CDH13 | 6.24e-07 | 114 | 321 | 12 | PS50268 |
| Domain | CA | DCHS2 CDHR1 CDHR3 FAT1 PCDHB11 PCDHB8 PCDHA5 CLSTN1 PCDHGB4 CDH6 CDH9 CDH13 | 6.86e-07 | 115 | 321 | 12 | SM00112 |
| Domain | Cadherin-like | DCHS2 CDHR1 CDHR3 FAT1 PCDHB11 PCDHB8 PCDHA5 CLSTN1 PCDHGB4 CDH6 CDH9 CDH13 | 7.54e-07 | 116 | 321 | 12 | IPR015919 |
| Domain | Cadherin | DCHS2 CDHR1 CDHR3 FAT1 PCDHB11 PCDHB8 PCDHA5 CLSTN1 PCDHGB4 CDH6 CDH9 CDH13 | 9.07e-07 | 118 | 321 | 12 | IPR002126 |
| Domain | Na_trans_cytopl | 1.25e-06 | 6 | 321 | 4 | IPR024583 | |
| Domain | Na_trans_cytopl | 1.25e-06 | 6 | 321 | 4 | PF11933 | |
| Domain | P-loop_NTPase | KIF21B DHX36 ATP6V1B2 DLG5 THNSL1 MYO5A ZGRF1 KIF1B LRRK2 DDX42 DNAH14 TUFM RAB8A KIF9 SAMD9L RAB24 DDX54 SHPRH RAB7A DNAH6 DNAH8 RAB5A RAB13 DYNC2H1 UPF1 AAGAB DMC1 ATAD3B ABCA5 SBNO1 SLFN13 ERCC6L2 SMARCA2 RAB21 SMC1B | 1.56e-06 | 848 | 321 | 35 | IPR027417 |
| Domain | PLCYc | 3.79e-06 | 15 | 321 | 5 | SM00149 | |
| Domain | PLipase_C_Pinositol-sp_Y | 3.79e-06 | 15 | 321 | 5 | IPR001711 | |
| Domain | PIPLC_Y_DOMAIN | 3.79e-06 | 15 | 321 | 5 | PS50008 | |
| Domain | EF-hand_like | 3.79e-06 | 15 | 321 | 5 | PF09279 | |
| Domain | PI-PLC-Y | 3.79e-06 | 15 | 321 | 5 | PF00387 | |
| Domain | PI-PLC_fam | 3.79e-06 | 15 | 321 | 5 | IPR001192 | |
| Domain | PLC_EF-hand-like | 3.79e-06 | 15 | 321 | 5 | IPR015359 | |
| Domain | Phosphorylase | 5.03e-06 | 3 | 321 | 3 | PF00343 | |
| Domain | PHOSPHORYLASE | 5.03e-06 | 3 | 321 | 3 | PS00102 | |
| Domain | Glycg_phsphrylas | 5.03e-06 | 3 | 321 | 3 | IPR011833 | |
| Domain | Glyco_trans_35 | 5.03e-06 | 3 | 321 | 3 | IPR000811 | |
| Domain | - | DHX36 ATP6V1B2 DLG5 THNSL1 ZGRF1 LRRK2 DDX42 DNAH14 TUFM RAB8A SAMD9L RAB24 DDX54 SHPRH RAB7A DNAH6 DNAH8 RAB5A RAB13 DYNC2H1 UPF1 AAGAB DMC1 ATAD3B ABCA5 SBNO1 SLFN13 ERCC6L2 SMARCA2 RAB21 SMC1B | 5.59e-06 | 746 | 321 | 31 | 3.40.50.300 |
| Domain | PLCXc | 1.04e-05 | 18 | 321 | 5 | SM00148 | |
| Domain | PI-PLC-X | 1.04e-05 | 18 | 321 | 5 | PF00388 | |
| Domain | PIPLC_X_DOMAIN | 1.39e-05 | 19 | 321 | 5 | PS50007 | |
| Domain | PLipase_C_PInositol-sp_X_dom | 1.39e-05 | 19 | 321 | 5 | IPR000909 | |
| Domain | Na_channel_asu | 1.66e-05 | 10 | 321 | 4 | IPR001696 | |
| Domain | Na_trans_assoc | 1.66e-05 | 10 | 321 | 4 | IPR010526 | |
| Domain | Na_trans_assoc | 1.66e-05 | 10 | 321 | 4 | PF06512 | |
| Domain | Cadherin_CS | DCHS2 CDHR1 FAT1 PCDHB11 PCDHB8 PCDHA5 PCDHGB4 CDH6 CDH9 CDH13 | 1.85e-05 | 109 | 321 | 10 | IPR020894 |
| Domain | C2 | DAB2IP INPP4A SYTL2 DYSF PLCB1 PLCB3 PLCD1 PLCL1 PLCZ1 MCTP1 SYT14 | 2.52e-05 | 137 | 321 | 11 | SM00239 |
| Domain | C2 | DAB2IP INPP4A SYTL2 DYSF PLCB1 PLCB3 PLCD1 PLCL1 PLCZ1 MCTP1 SYT14 | 3.52e-05 | 142 | 321 | 11 | PS50004 |
| Domain | GDS_CDC24_CS | 4.98e-05 | 39 | 321 | 6 | IPR001331 | |
| Domain | - | DAB2IP INPP4A SYTL2 DYSF PLCB1 PLCB3 PLCD1 PLCL1 PLCZ1 MCTP1 SYT14 | 5.14e-05 | 148 | 321 | 11 | 2.60.40.150 |
| Domain | - | 5.82e-05 | 25 | 321 | 5 | 3.20.20.190 | |
| Domain | PLC-like_Pdiesterase_TIM-brl | 5.82e-05 | 25 | 321 | 5 | IPR017946 | |
| Domain | MT | 7.48e-05 | 14 | 321 | 4 | PF12777 | |
| Domain | AAA_8 | 7.48e-05 | 14 | 321 | 4 | PF12780 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.48e-05 | 14 | 321 | 4 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.48e-05 | 14 | 321 | 4 | IPR024743 | |
| Domain | C2 | 9.00e-05 | 131 | 321 | 10 | PF00168 | |
| Domain | DHC_fam | 1.01e-04 | 15 | 321 | 4 | IPR026983 | |
| Domain | Dynein_heavy | 1.01e-04 | 15 | 321 | 4 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.01e-04 | 15 | 321 | 4 | IPR004273 | |
| Domain | C2_dom | DAB2IP INPP4A SYTL2 DYSF PLCB1 PLCB3 PLCD1 PLCL1 PLCZ1 MCTP1 SYT14 | 1.30e-04 | 164 | 321 | 11 | IPR000008 |
| Domain | Beta-TrCP_D | 2.94e-04 | 2 | 321 | 2 | IPR021977 | |
| Domain | Beta-TrCP_D | 2.94e-04 | 2 | 321 | 2 | PF12125 | |
| Domain | Beta-TrCP_D | 2.94e-04 | 2 | 321 | 2 | SM01028 | |
| Domain | PH | DAB2IP ARHGAP42 TRIO KIF1B OBSCN PLEKHS1 ARHGAP25 PLCD1 PLCL1 VAV1 ARHGEF6 ARHGEF5 ELMO2 SOS2 | 3.43e-04 | 278 | 321 | 14 | SM00233 |
| Domain | PH_DOMAIN | DAB2IP ARHGAP42 TRIO KIF1B OBSCN PLEKHS1 ARHGAP25 PLCD1 PLCL1 VAV1 ARHGEF6 ARHGEF5 ELMO2 SOS2 | 3.56e-04 | 279 | 321 | 14 | PS50003 |
| Domain | PH_domain | DAB2IP ARHGAP42 TRIO KIF1B OBSCN PLEKHS1 ARHGAP25 PLCD1 PLCL1 VAV1 ARHGEF6 ARHGEF5 ELMO2 SOS2 | 3.69e-04 | 280 | 321 | 14 | IPR001849 |
| Domain | PH_dom-like | DAB2IP ARHGAP42 TRIO KIF1B OBSCN PLEKHS1 JAK2 PLCB1 ARHGAP25 PLCB3 PLCD1 PLCL1 VAV1 ARHGEF6 ARHGEF5 FRMD4A ELMO2 SOS2 | 4.43e-04 | 426 | 321 | 18 | IPR011993 |
| Domain | EF-hand-dom_pair | S100A1 SCN1A SCN3A SCN8A PLCB1 PLCB3 PLCD1 PLCL1 UTRN PLS3 PLCZ1 S100A16 PKD2L1 SLC25A12 | 4.72e-04 | 287 | 321 | 14 | IPR011992 |
| Domain | DH_1 | 7.34e-04 | 63 | 321 | 6 | PS00741 | |
| Domain | - | 8.73e-04 | 3 | 321 | 2 | 1.10.1370.10 | |
| Domain | Neurolysin/TOP_N | 8.73e-04 | 3 | 321 | 2 | IPR024080 | |
| Domain | Neurolysin/TOP_dom2 | 8.73e-04 | 3 | 321 | 2 | IPR024077 | |
| Domain | - | 8.73e-04 | 3 | 321 | 2 | 1.20.1050.40 | |
| Domain | PLC-beta_CS | 8.73e-04 | 3 | 321 | 2 | IPR009535 | |
| Domain | PLC-beta_C | 8.73e-04 | 3 | 321 | 2 | PF08703 | |
| Domain | Pept_M3A_M3B | 8.73e-04 | 3 | 321 | 2 | IPR001567 | |
| Domain | ANF_RECEPTORS | 8.73e-04 | 3 | 321 | 2 | PS00458 | |
| Domain | PLC-beta_C | 8.73e-04 | 3 | 321 | 2 | IPR014815 | |
| Domain | Peptidase_M3 | 8.73e-04 | 3 | 321 | 2 | PF01432 | |
| Domain | ANPR/GUC | 8.73e-04 | 3 | 321 | 2 | IPR001170 | |
| Domain | DUF1154 | 8.73e-04 | 3 | 321 | 2 | PF06631 | |
| Domain | RhoGEF | 1.10e-03 | 68 | 321 | 6 | SM00325 | |
| Domain | - | DAB2IP ARHGAP42 TRIO KIF1B OBSCN PLEKHS1 ARHGAP25 PLCB3 PLCD1 PLCL1 VAV1 ARHGEF6 ARHGEF5 FRMD4A ELMO2 SOS2 | 1.27e-03 | 391 | 321 | 16 | 2.30.29.30 |
| Domain | RhoGEF | 1.28e-03 | 70 | 321 | 6 | PF00621 | |
| Domain | DH_2 | 1.28e-03 | 70 | 321 | 6 | PS50010 | |
| Domain | - | 1.38e-03 | 71 | 321 | 6 | 1.20.900.10 | |
| Domain | DH-domain | 1.38e-03 | 71 | 321 | 6 | IPR000219 | |
| Domain | ATPase_dyneun-rel_AAA | 1.59e-03 | 14 | 321 | 3 | IPR011704 | |
| Domain | AAA_5 | 1.59e-03 | 14 | 321 | 3 | PF07728 | |
| Domain | Dynein_heavy_dom-2 | 1.59e-03 | 14 | 321 | 3 | IPR013602 | |
| Domain | DHC_N2 | 1.59e-03 | 14 | 321 | 3 | PF08393 | |
| Domain | RAB | 1.59e-03 | 73 | 321 | 6 | PS51419 | |
| Domain | PC1 | 1.73e-03 | 4 | 321 | 2 | IPR000434 | |
| Domain | PLC-beta | 1.73e-03 | 4 | 321 | 2 | IPR016280 | |
| Pathway | WP_GPR40_PATHWAY | 3.73e-06 | 15 | 242 | 5 | M39526 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.63e-05 | 48 | 242 | 7 | M26964 | |
| Pathway | REACTOME_INOSITOL_PHOSPHATE_METABOLISM | 1.63e-05 | 48 | 242 | 7 | MM14589 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 7.01e-05 | 26 | 242 | 5 | M27053 | |
| Pathway | REACTOME_SYNTHESIS_OF_IP3_AND_IP4_IN_THE_CYTOSOL | 1.02e-04 | 28 | 242 | 5 | MM14711 | |
| Pathway | WP_DRAVET_SYNDROME | 1.02e-04 | 28 | 242 | 5 | M45519 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 1.21e-04 | 29 | 242 | 5 | M29808 | |
| Pubmed | DHX36 MYO5A UGGT1 COPB2 DDX42 TUFM FASN FAM120A NUP210 EIF3L NUFIP2 DDX54 PYGB PYGL UTRN CUL4B MRE11 PDCD6IP PUF60 PRDX4 NOL11 LMNB2 HEATR1 UPF1 DIS3 PPP2R1A IGF2BP2 PBRM1 SND1 SMARCA2 ELAVL1 RBM34 | 6.90e-14 | 653 | 335 | 32 | 22586326 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | DHX36 ATR TRIO VPS13C UGGT1 ETF1 COPB2 DDX42 TUFM TXN FASN FAM120A H4C1 NUP210 EIF3L DDX54 RAB7A AP1M1 ALDH3A2 PLS3 MRE11 PSAT1 PDCD6IP HSDL2 DYNC2H1 PUF60 PRDX4 NOL11 LMNB2 HEATR1 UPF1 DIS3 CYFIP2 PPP2R1A TRAP1 NAMPT PBRM1 SND1 SBNO1 VPS35 SUPT16H UBA6 MTR ELAVL1 TOP2A RBM34 | 7.84e-13 | 1425 | 335 | 46 | 30948266 |
| Pubmed | MON2 KIF21B DHX36 MASP1 INPP4A INPPL1 DHDDS HMGCR SLC7A11 PTCHD1 FASN UBE3A FDFT1 MIB1 DDX54 TAF6 ALDH3A2 OBI1 WDR24 DENND5B MAPKAP1 DPH1 MRE11 COG2 PDCD6IP SPG11 HEATR1 UPF1 TEAD1 TFAP4 NAMPT PBRM1 SBNO1 ELMO2 VPS35 SUPT16H PRKAG1 PAK2 ELAVL1 KDM4A RERE CDH6 RBM34 HTT | 1.07e-12 | 1327 | 335 | 44 | 32694731 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX36 DLG5 MYO5A UGGT1 ETF1 CD109 MAP3K20 ABT1 TUFM KRT80 TXN FASN FAM120A H4C1 KLHL7 ATXN2 NUP210 EIF3L NUFIP2 DDX54 AP1M1 POLR1B PLS3 NOL8 MRE11 PDCD6IP PUF60 ANXA3 NOL11 LMNB2 HEATR1 UPF1 GSTM1 PPP1R10 PPP2R1A ATAD3B IGF2BP2 SND1 SUPT16H ELAVL1 TOP2A RBM34 | 2.88e-12 | 1257 | 335 | 42 | 36526897 |
| Pubmed | FAM184B ATP6V1B2 DLG5 MYO5A UGGT1 DDX42 DNAJB14 TMCC3 TXN COCH FAM120A SACS FDFT1 NUP210 MIB1 DDX54 RAB7A SIPA1L2 ALDH3A2 PLS3 NOL8 MAPKAP1 DPH1 HSDL2 DYNC2H1 PRDX4 SHMT1 NOL11 SPG11 LMNB2 HEATR1 UPF1 PCF11 TUBGCP6 ATAD3B SND1 INF2 VPS35 SUPT16H UBA6 MTR MARVELD2 CRYBG3 QRSL1 RBM34 EPHA7 | 3.40e-12 | 1487 | 335 | 46 | 33957083 | |
| Pubmed | ATR ETF1 COPB2 DDX42 ABT1 TUFM FASN H4C1 UBE3A EIF3L PYGB PYGL TAF6 NNMT CUL4B MRE11 PDCD6IP PUF60 ANXA3 WDR70 NOL11 LMNB2 UPF1 DIS3 TFAP4 TRIM33 PPP1R10 PPP2R1A NAMPT PBRM1 SND1 SBNO1 SUPT16H SMARCA2 UBA6 PAK2 TOP2A | 5.12e-12 | 1014 | 335 | 37 | 32416067 | |
| Pubmed | Expression of testicular germ cell genes identified by differential display analysis. | ANKRD20A3P ANKRD20A8P ANKRD18B ANKRD20A4P ANKRD18A ANKRD20A1 | 2.10e-11 | 8 | 335 | 6 | 12634303 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | TRIO MYO5A INPP4A VPS13C KIF1B OBSCN ADGRV1 PDE10A DNAH14 ITFG1 JAK2 HOXC4 DENND1B FAM120A ATXN2 TGFBRAP1 NUP210 SHPRH RAB7A KATNIP XYLB UTRN FBXW11 AMD1 DIP2B PSAT1 PDCD6IP B3GALNT2 SAMD4B WDR70 INTS8 TFAP4 MIPOL1 CNNM4 ATAD3B THOP1 INF2 ASMTL SMARCA2 PRKAG1 UBA6 RERE HTT SOS2 | 4.64e-11 | 1489 | 335 | 44 | 28611215 |
| Pubmed | DHX36 DLGAP1 ATP6V1B2 TRIO MYO5A INPP4A KIF1B ETF1 COPB2 ALDH1L1 TUFM TXN FASN FAM120A SACS SCN2A EIF3L NUFIP2 RAB7A PYGB PLCL1 SIPA1L2 DNAH6 NOS1 UTRN PLS3 PDCD6IP SLC2A14 DPYSL4 GRIA2 UPF1 CYFIP2 GSTM1 PPP2R1A ATAD3B MLIP SLC25A12 P2RX3 SND1 INF2 VCAN VPS35 ELAVL1 | 4.67e-11 | 1431 | 335 | 43 | 37142655 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | DHX36 ETF1 TUFM RAB8A FASN FAM120A KLHL7 FDFT1 EIF3L MIB1 DDX54 AP1M1 PYGL POLR1B PPIP5K2 TAF6 RAB5A RAB13 MRE11 PDCD6IP HSDL2 PUF60 PRDX4 NOL11 HEATR1 UPF1 DIS3 TRAP1 IGF2BP2 NAMPT PBRM1 SLC25A12 SND1 SUPT16H SMARCA2 PRKAG1 PAK2 ELAVL1 RAB21 TOP2A RBM34 | 4.85e-11 | 1318 | 335 | 41 | 30463901 |
| Pubmed | MON2 DHX36 C3orf38 UGGT1 COPB2 COCH NUP210 DDX54 RAB7A POLR1B MTARC2 SIPA1L2 CUL4B MAPKAP1 AMD1 COG2 DYNC2H1 HEATR1 MSI1 MAP3K6 DIS3 TUBGCP6 TRAP1 SLC25A12 VPS35 MTR RAB21 | 5.81e-11 | 606 | 335 | 27 | 36538041 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | MON2 HEXA ATP6V1B2 INPPL1 UGGT1 KIF1B ETF1 COPB2 UBAP1 TUFM TXN FASN H4C1 UBE3A EIF3L PYGB AP1M1 PYGL TIMELESS PLCB3 PLS3 OARD1 CUL4B MRE11 PSAT1 PDCD6IP PUF60 PRDX4 SHMT1 DIS3 PPP2R1A TRAP1 NAMPT THOP1 SND1 SBNO1 ASMTL VPS35 SUPT16H UBA6 MTR PAK2 HTT | 7.87e-11 | 1455 | 335 | 43 | 22863883 |
| Pubmed | DAB2IP KIF21B DLGAP1 PDE4A TRIO MYO5A ETF1 LMTK3 BCOR FAM120A KLHL7 ATXN2 UBE3A NUFIP2 KCNJ16 PLCB1 RAB7A PLCL1 NOS1 DIP2B PDCD6IP DPYSL4 GRIA2 LMNB2 UPF1 CYFIP2 PPP2R1A PBRM1 RGS6 SUPT16H UBA6 PAK2 ELAVL1 TMEM240 | 9.48e-11 | 963 | 335 | 34 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DHX36 MYO5A COPB2 MAP3K20 TUFM TXN FASN FAM120A H4C1 UBE3A EIF3L MIB1 DDX54 RAB7A PYGB AP1M1 PYGL POLR1B UTRN RAB13 BTRC MRE11 PDCD6IP WDR70 NOL11 LMNB2 HEATR1 UPF1 DIS3 PPP2R1A IGF2BP2 NAMPT SLC25A12 SND1 INF2 VPS35 SUPT16H SMARCA2 ELAVL1 TOP2A RBM34 | 1.07e-10 | 1353 | 335 | 41 | 29467282 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 UGGT1 COPB2 CD109 MYORG GGT7 FASN FAM120A NUP210 DDX54 RAB7A NID1 PYGL SIPA1L2 ALDH3A2 UTRN RAB5A PLS3 BTRC FBXW11 MRE11 DIP2B PDCD6IP ANXA3 PRDX4 WDR70 HEATR1 DIS3 CNNM4 PPP2R1A IGF2BP2 THOP1 VPS35 SORL1 | 1.28e-10 | 974 | 335 | 34 | 28675297 |
| Pubmed | ETF1 COPB2 TUFM FASN NUP210 EIF3L RAB7A AP1M1 ALDH3A2 PLS3 CUL4B MRE11 PDCD6IP PUF60 NOL11 LMNB2 HEATR1 UPF1 DIS3 TRIM33 PPP2R1A TRAP1 NAMPT SND1 VPS35 SUPT16H ELAVL1 | 1.82e-10 | 638 | 335 | 27 | 33239621 | |
| Pubmed | FAM184B MYO5A TTC16 UGGT1 DDX42 PDE10A NEB DNAJB14 TUFM RAB8A FASN MIA2 SACS H4C1 PPIP5K2 CTAGE4 SIPA1L2 DNAH6 DNAH8 OBI1 PRDX4 GRIA2 SPG11 LMNB2 CTAGE6 HEATR1 CYFIP2 MIPOL1 PCF11 TRAP1 ATAD3B MLIP SLC25A12 SND1 SBNO1 VPS35 CTAGE8 SUPT16H PCDHGB4 CTAGE15 RAB21 TOP2A | 2.08e-10 | 1442 | 335 | 42 | 35575683 | |
| Pubmed | DHX36 THNSL1 ATR TUFM LPIN1 FAM120A PYGB AP1M1 TIMELESS PLCB3 PPIP5K2 MAPKAP1 DIP2B TBX3 ARHGEF5 SAMD4B CLSTN1 MAP3K6 DIS3 IBTK NAMPT ELMO2 AACS MTR CRYBG3 SORL1 | 1.31e-09 | 650 | 335 | 26 | 38777146 | |
| Pubmed | ATP6V1B2 SLC7A11 TUFM TXN FASN H4C1 EIF3L RAB7A PYGL PLS3 PDCD6IP PRDX4 NOL11 HEATR1 UPF1 CNNM4 PPP2R1A ATAD3B SND1 VPS35 RAB21 TOP2A | 2.54e-09 | 484 | 335 | 22 | 31995728 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | GALNT1 SARM1 COPB2 DNAJB14 TUFM GGT7 FASN UBE3A FDFT1 NUP210 EIF3L NUFIP2 TIMELESS ALDH3A2 PDCD6IP HSDL2 DYNC2H1 LMNB2 HEATR1 UPF1 CLSTN1 INTS8 CNNM4 PPP2R1A ATAD3B SLC25A12 SND1 INF2 VPS35 MTR CERS1 | 3.53e-09 | 942 | 335 | 31 | 31073040 |
| Pubmed | ATP6V1B2 MYO5A VPS13C PLEKHS1 TUFM FASN FAM120A SCN2A EIF3L RAB7A PYGB ALDH3A2 RAB13 CUL4B PDCD6IP PRDX4 LMNB2 UPF1 INTS8 TRAP1 SLC25A12 SND1 TLR1 VPS35 ELAVL1 RAB21 TOP2A SOS2 | 6.10e-09 | 803 | 335 | 28 | 36517590 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | HEXA DHX36 GALNT1 ATR UGGT1 CD109 HMGCR SLC7A11 DNAJB14 MYORG ITFG1 GGT7 BMP6 FAT1 COCH MIA2 FDFT1 NUP210 NID1 TIMELESS ALDH3A2 DNASE1L1 PLS3 NPR1 COL12A1 ANPEP PRDX4 B3GALNT2 CLSTN1 VPS35 CERS1 RAB21 CDH13 HTT SORL1 | 7.44e-09 | 1201 | 335 | 35 | 35696571 |
| Pubmed | 8.46e-09 | 4 | 335 | 4 | 17537961 | ||
| Pubmed | 8.46e-09 | 4 | 335 | 4 | 35031483 | ||
| Pubmed | 8.46e-09 | 4 | 335 | 4 | 29578003 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | DHX36 COPB2 DDX42 STK38 TUFM TXN FASN FAM120A ATXN2 EIF3L NUFIP2 RAB7A CUL4B PSAT1 PUF60 PRDX4 SHMT1 HEATR1 UPF1 MSI1 DIS3 PPP2R1A IGF2BP2 SUPT16H ELAVL1 TOP2A | 9.07e-09 | 714 | 335 | 26 | 28302793 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | TRIO INPP4A LMTK3 FAM120A ATXN2 NUFIP2 SCN8A PLCB1 NID1 PLCB3 BTRC FBXW11 DIP2B HSDL2 WDR70 UPF1 TUBGCP6 PPP2R1A PBRM1 ELAVL1 HTT | 9.55e-09 | 475 | 335 | 21 | 31040226 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | VPS13C COPB2 OBSCN ANKRD20A3P MAGEB6 DNAH14 TUFM JAK2 SAMD9L H4C1 SCN3A EIF3L SCN8A KCNS2 ANKRD18A PLCB3 MTARC2 UTRN BANK1 MRE11 PCDHA5 LMNB2 PARP14 DIPK2B MIPOL1 TNFAIP1 | 1.67e-08 | 736 | 335 | 26 | 29676528 |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | DLG5 UGGT1 KIF1B ETF1 COPB2 DNAJB14 TUFM KRT80 NLN FASN H4C1 FDFT1 RAB7A PYGB AP1M1 PYGL NNMT UTRN RAB13 MRE11 PDCD6IP S100A16 PUF60 PRDX4 DPYSL4 UPF1 DIS3 PPP2R1A IGF2BP2 NAMPT SND1 INF2 SUPT16H SMARCA2 PRKAG1 UBA6 TOP2A | 1.86e-08 | 1367 | 335 | 37 | 32687490 |
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | ATP6V1B2 VPS13C LRRK2 ALDH1L1 ADGRV1 NEB DYSF RAB8A TXN FASN FAT1 RAB7A AP1M1 NID1 PLCD1 UTRN RAB13 SERPINA7 CUL4B COL6A3 PSAT1 PDCD6IP ANPEP S100A16 DYNC2H1 ANXA3 SHMT1 CYFIP2 VPS35 RAB21 SORL1 | 2.01e-08 | 1016 | 335 | 31 | 19056867 |
| Pubmed | ARHGAP42 TRIO MYO5A INPPL1 UGGT1 COPB2 DDX42 RAB8A MIB1 ARHGAP25 PPIP5K2 UTRN RAB5A BTRC VAV1 ARHGEF6 PUF60 ARHGEF5 PRDX4 LMNB2 HEATR1 MSI1 PPP1R10 PPP2R1A SLC25A12 ELMO2 PAK2 SORL1 SOS2 | 2.68e-08 | 916 | 335 | 29 | 32203420 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | DHX36 MYO5A DDX42 MAP3K20 ABT1 TXN FASN FAM120A H4C1 ATXN2 EIF3L NUFIP2 DDX54 NOL8 PUF60 SAMD4B NOL11 HEATR1 UPF1 MSI1 PPP1R10 IGF2BP2 SND1 SUPT16H ELAVL1 TOP2A RBM34 | 2.70e-08 | 807 | 335 | 27 | 22681889 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYO5A UGGT1 COPB2 DDX42 STK38 TUFM TXN FASN FAM120A H4C1 EIF3L NUFIP2 RAB7A PYGL OBI1 PLS3 MRE11 PSAT1 PDCD6IP PUF60 PRDX4 SHMT1 UPF1 MSI1 CYFIP2 PPP2R1A TRAP1 IGF2BP2 SND1 VPS35 SUPT16H ELAVL1 RAB21 | 2.90e-08 | 1149 | 335 | 33 | 35446349 |
| Pubmed | KIF21B DLG5 STK38 SCN1A EIF3L PLCB1 DNAH6 DNAH8 COL6A3 DYNC2H1 LMNB2 PARP14 TRAP1 | 3.89e-08 | 187 | 335 | 13 | 26460568 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DHX36 CYP4F8 UGGT1 KIF1B COPB2 ZBTB24 TUFM RAB8A TXN ATXN2 FDFT1 EIF3L RAB7A PYGM RAB5A OBI1 PLS3 FBXW11 MMS22L HTR1B PDCD6IP PUF60 SAMD4B HEATR1 CNNM4 PPP2R1A IBTK ATAD3B IGF2BP2 SLC25A12 SND1 ZNF277 VPS35 MTR PAK2 | 3.90e-08 | 1284 | 335 | 35 | 17353931 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ETF1 DDX42 BCOR TXN FASN H4C1 NUFIP2 TAF6 SIPA1L2 ALDH3A2 UTRN ANAPC4 NOL8 MRE11 PSAT1 PUF60 WDR70 DPYSL4 HEATR1 UPF1 DIS3 PPP1R10 IBTK TRAP1 IGF2BP2 NAMPT SND1 PAK2 TOP2A | 4.07e-08 | 934 | 335 | 29 | 33916271 |
| Pubmed | 4.20e-08 | 5 | 335 | 4 | 1679748 | ||
| Pubmed | 4.20e-08 | 5 | 335 | 4 | 8812438 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | ATR TUFM TXN FASN H4C1 NUP210 EIF3L NUFIP2 PLS3 MRE11 PSAT1 PDCD6IP LMNB2 DIS3 PPP2R1A TRAP1 ATAD3B IGF2BP2 SND1 SUPT16H | 5.15e-08 | 477 | 335 | 20 | 31300519 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | DHX36 THNSL1 VPS13C SARM1 TMCC3 TUFM RAB8A FAM120A MIA2 ATXN2 MIB1 DDX54 RAB7A MTARC2 ALDH3A2 RAB13 DIP2B HSDL2 NOL11 LMNB2 HEATR1 UPF1 MSI1 IBTK TRAP1 ATAD3B IGF2BP2 SLC25A12 SND1 INF2 SUPT16H MTR ELAVL1 RERE CRYBG3 QRSL1 TOP2A RBM34 | 6.12e-08 | 1496 | 335 | 38 | 32877691 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ATP6V1B2 MYO5A UGGT1 DDX42 TUFM KRT80 FASN SACS H4C1 NUP210 DDX54 RAB7A UTRN MRE11 PDCD6IP PUF60 NOL11 LMNB2 HEATR1 PPP1R10 PPP2R1A TRAP1 IGF2BP2 PBRM1 SND1 SUPT16H UBA6 ELAVL1 RAB21 TOP2A | 8.34e-08 | 1024 | 335 | 30 | 24711643 |
| Pubmed | COPB2 TUFM KRT80 FASN EIF3L NUFIP2 DDX54 AP1M1 CUL4B PDCD6IP PUF60 NOL11 HEATR1 UPF1 DIS3 PPP2R1A ATAD3B IGF2BP2 VPS35 SUPT16H ELAVL1 TOP2A RBM34 | 8.69e-08 | 641 | 335 | 23 | 36057605 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | KIF21B DCHS2 ETF1 OBSCN ALDH1L1 NEB DYSF DDX54 SHPRH NID1 ANAPC4 SPG11 PPP1R10 PPP2R1A SLC25A12 VPS35 ERCC6L2 UBA6 KDM4A RBM34 | 1.00e-07 | 497 | 335 | 20 | 36774506 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | UGGT1 ETF1 COPB2 ALDH1L1 TUFM TXN FASN SLC13A4 SCN8A RAB7A PYGB UTRN RAB5A PDCD6IP DYNC2H1 PUF60 PRDX4 UPF1 CYFIP2 EPG5 PPP2R1A TRAP1 NAMPT THOP1 SND1 ELAVL1 | 1.03e-07 | 807 | 335 | 26 | 30575818 |
| Pubmed | DHX36 PDE4A COPB2 STK38 TUFM KRT80 RAB8A TXN FASN FAM120A H4C1 FDFT1 SCN1A SCN3A NUP210 EIF3L AP1M1 PLS3 MRE11 PUF60 PRDX4 MSI1 AAGAB GSTM1 PPP2R1A TRAP1 ATAD3B IGF2BP2 P2RX3 SND1 SUPT16H ELAVL1 | 1.03e-07 | 1153 | 335 | 32 | 29845934 | |
| Pubmed | COPB2 TUFM GGT7 H4C1 EIF3L PYGB PYGL PLS3 CUL4B MRE11 PDCD6IP PUF60 WDR70 NOL11 DIS3 PPP2R1A ATAD3B SND1 VPS35 | 1.04e-07 | 451 | 335 | 19 | 36168627 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | COPB2 DDX42 STK38 RAB8A FASN FAM120A EIF3L MIB1 PYGM TIMELESS ALDH3A2 OBI1 PLS3 ANAPC4 CUL4B NPR1 PDCD6IP ANPEP TSEN54 TRIM5 PCF11 TUBGCP6 PPP1R10 PPP2R1A TRAP1 ATAD3B PBRM1 INF2 SMARCA2 PLK4 TOP2A CRBN | 1.07e-07 | 1155 | 335 | 32 | 20360068 |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | MON2 ZGRF1 DYSF BIN2 UTRN OBI1 MRE11 COL6A3 MMS22L COL12A1 PPARG DIS3 LEPR THOP1 PBRM1 CDH6 EPHA7 | 1.11e-07 | 363 | 335 | 17 | 14691545 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | COPB2 TUFM FASN UBE3A EIF3L RAB7A AP1M1 POLR1B TIMELESS DNAH8 MRE11 NOL11 HEATR1 UPF1 TRIM33 IGF2BP2 NAMPT SLC25A12 SND1 SUPT16H SMARCA2 ELAVL1 RAB21 TOP2A | 1.16e-07 | 704 | 335 | 24 | 29955894 |
| Pubmed | DDX42 STK38 TUFM FASN FAM120A H4C1 ATXN2 UBE3A EIF3L NUFIP2 OBI1 PLS3 MRE11 PRDX4 UPF1 DIS3 PPP2R1A IGF2BP2 SND1 ELAVL1 RBM34 | 1.19e-07 | 551 | 335 | 21 | 34728620 | |
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 1.25e-07 | 6 | 335 | 4 | 23652591 | |
| Pubmed | COPB2 ABT1 TUFM RAB8A FASN H4C1 FDFT1 EIF3L DDX54 ALDH3A2 UTRN HSDL2 PUF60 NOL11 LMNB2 HEATR1 UPF1 PARP14 TRAP1 ATAD3B IGF2BP2 SUPT16H RAB21 RBM34 | 1.39e-07 | 711 | 335 | 24 | 33022573 | |
| Pubmed | DAB2IP MON2 ATP6V1B2 TRIO MYO5A UGGT1 COPB2 BCOR ATXN2 FDFT1 NUP210 NUFIP2 MIB1 DDX54 ALDH3A2 UTRN BTRC FBXW11 PSAT1 HSDL2 CYFIP2 PCF11 CNNM4 PPP1R10 PPP2R1A IGF2BP2 SUPT16H MARVELD2 CRYBG3 PLK4 | 1.40e-07 | 1049 | 335 | 30 | 27880917 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | ETF1 COPB2 FDFT1 EIF3L RAB7A PYGB AP1M1 PYGL PDCD6IP PUF60 LMNB2 UPF1 DIS3 IGF2BP2 NAMPT SND1 VPS35 SUPT16H UBA6 ELAVL1 RAB21 TOP2A | 1.40e-07 | 607 | 335 | 22 | 39147351 |
| Pubmed | MON2 SPAM1 BCOR TUFM FAT1 FAM120A H4C1 XYLB TAF6 SIPA1L2 VAV1 ANAPC4 CUL4B MRE11 TBX3 MSI1 TUBGCP6 TRIM33 ATAD3B IGF2BP2 PBRM1 SLC25A12 MCTP1 SUPT16H SMARCA2 MTR RERE CRYBG3 TOP2A TCTN2 SORL1 | 1.62e-07 | 1116 | 335 | 31 | 31753913 | |
| Pubmed | DHX36 COPB2 TUFM TXN FASN FAM120A EIF3L PLS3 PUF60 PRDX4 UPF1 MSI1 PCF11 PPP2R1A TRAP1 IGF2BP2 NAMPT ELAVL1 TOP2A | 1.90e-07 | 469 | 335 | 19 | 37314180 | |
| Pubmed | MON2 UGGT1 COPB2 CD109 HMGCR TUFM FASN FAM120A FDFT1 NUP210 EIF3L DDX54 ALDH3A2 PLS3 BTRC FBXW11 COG2 PSAT1 PDCD6IP PRDX4 HEATR1 UPF1 DIS3 CNNM4 PPP2R1A TRAP1 ATAD3B IGF2BP2 NAMPT SND1 INF2 VPS35 SUPT16H ELAVL1 TOP2A RBM34 | 2.06e-07 | 1440 | 335 | 36 | 30833792 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DAB2IP MON2 KIF1B SLC7A11 RAB8A SLC9C1 KLHL7 EIF3L NUFIP2 PYGL KATNIP PPIP5K2 PLS3 ARHGEF6 WDR24 CUL4B MAPKAP1 MRE11 HSDL2 DYNC2H1 WDR70 HEATR1 DIS3 MIPOL1 CNNM4 PPP1R10 PPP2R1A TRAP1 SND1 SBNO1 SUPT16H RAB21 TCTN2 SORL1 | 2.36e-07 | 1321 | 335 | 34 | 27173435 |
| Pubmed | DHX36 DDX42 PLEKHS1 ABT1 FASN FAM120A NUP210 NUFIP2 DDX54 POLR1B ALDH3A2 NOL8 MRE11 PUF60 NOL11 HEATR1 UPF1 INTS8 TFAP4 PCF11 ATAD3B IGF2BP2 PBRM1 ELAVL1 TOP2A RBM34 | 2.61e-07 | 847 | 335 | 26 | 35850772 | |
| Pubmed | The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA. | UGGT1 CD109 FASN FAM120A FDFT1 EIF3L SHPRH PYGB HEATR1 PARP14 TRIM33 PPP2R1A TNFAIP1 TOP2A | 3.06e-07 | 262 | 335 | 14 | 36880596 |
| Pubmed | The functional interactome of PYHIN immune regulators reveals IFIX is a sensor of viral DNA. | ATP6V1B2 FAM120A H4C1 ATXN2 EIF3L NUFIP2 DDX54 ALDH3A2 PLS3 NOL8 MRE11 NOL11 UPF1 TFAP4 SUPT16H RBM34 | 3.49e-07 | 349 | 335 | 16 | 25665578 |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | BCOR DNAJB14 LPIN1 FAM120A SIPA1L2 BTRC FBXW11 MRE11 NOL11 TFAP4 NAMPT SUPT16H ELAVL1 | 4.74e-07 | 232 | 335 | 13 | 25515538 |
| Pubmed | Cloning of Rab GTPases expressed in human skeletal muscle: studies in insulin-resistant subjects. | 5.74e-07 | 8 | 335 | 4 | 9918381 | |
| Pubmed | MON2 UGGT1 TUFM FDFT1 PYGB AP1M1 TIMELESS ALDH3A2 FBXW11 CUL4B COG2 MSI1 TRIM33 PPP1R10 PPP2R1A TRAP1 NAMPT ELMO2 VPS35 TOP2A | 6.59e-07 | 560 | 335 | 20 | 35241646 | |
| Pubmed | In-depth proteomic analyses of exosomes isolated from expressed prostatic secretions in urine. | MON2 HEXA ATP6V1B2 MYO5A ALDH1L1 DYSF ITFG1 TXN FASN SERPINI2 H4C1 AFM RAB7A PYGB NID1 PYGL PYGM SERPINA7 COL6A3 PDCD6IP ANPEP ANXA3 SHMT1 SERPINA6 CYFIP2 PPP2R1A NAMPT RAB21 CDH13 | 6.81e-07 | 1070 | 335 | 29 | 23533145 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | HEXA GALNT1 UGGT1 COPB2 DDX42 CD109 TUFM TMPRSS11B RAB8A TXN FASN FAT1 ATXN2 RAB7A NID1 ALDH3A2 DNAH6 RAB5A PRDX4 PON3 OAS2 CLSTN1 DIS3 CYFIP2 TRAP1 ATAD3B IGF2BP2 THOP1 SLC25A12 SND1 INF2 VPS35 SUPT16H RERE RAB21 | 7.02e-07 | 1451 | 335 | 35 | 30550785 |
| Pubmed | BCAR1 promotes proliferation and cell growth in lung adenocarcinoma via upregulation of POLR2A. | MON2 ASIC2 STK38 DYSF RAB8A DUS2 NUP210 NUFIP2 XYLB NOL8 SHMT1 MSI1 AAGAB SLC25A12 MTR PAK2 HTT | 8.23e-07 | 419 | 335 | 17 | 33001583 |
| Pubmed | DHX36 UGGT1 COPB2 BCOR TUFM TXN FASN FAM120A H4C1 EIF3L ALDH3A2 RAB5A PLS3 ANAPC4 CUL4B MRE11 HSDL2 PUF60 PRDX4 SAMD4B SPG11 LMNB2 UPF1 PPP2R1A TRAP1 IGF2BP2 SLC25A12 SND1 VPS35 SUPT16H PRKAG1 ELAVL1 RBM34 | 8.75e-07 | 1335 | 335 | 33 | 29229926 | |
| Pubmed | Increased expression of cSHMT, Tbx3 and utrophin in plasma of ovarian and breast cancer patients. | 8.86e-07 | 3 | 335 | 3 | 16049973 | |
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 12610651 | ||
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 18784617 | ||
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 28518218 | ||
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 23859570 | ||
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 28483528 | ||
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 17544618 | ||
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 32845893 | ||
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 17928448 | ||
| Pubmed | 8.86e-07 | 3 | 335 | 3 | 14973256 | ||
| Pubmed | MON2 HEXA TRIO VPS13C UGGT1 SYTL2 DDX42 UBAP1 HMGCR GGT7 FAM120A EIF3L NUFIP2 POLR1B PPIP5K2 CUL4B PRDX4 WDR70 SPG11 LMNB2 IBTK MTR RAB21 | 8.99e-07 | 733 | 335 | 23 | 34672954 | |
| Pubmed | 1.03e-06 | 9 | 335 | 4 | 15746173 | ||
| Pubmed | 1.03e-06 | 9 | 335 | 4 | 16382098 | ||
| Pubmed | 1.11e-06 | 20 | 335 | 5 | 29158485 | ||
| Pubmed | TRIO MYO5A UGGT1 ETF1 FDFT1 DDX54 AP1M1 ALDH3A2 ANAPC4 CUL4B AMD1 TBX3 ANXA3 PPP1R10 SLC25A12 SND1 SUPT16H SMARCA2 ELAVL1 TOP2A RBM34 | 1.16e-06 | 634 | 335 | 21 | 34591612 | |
| Pubmed | KIF21B DHX36 DLG5 VPS13C ADGRV1 BCOR MIB1 PLCB1 PPIP5K2 PDCD6IP SPG11 ERI2 SLC7A6 DIS3 TUBGCP6 TRIM33 IBTK ABCA5 KDM4A | 1.16e-06 | 529 | 335 | 19 | 14621295 | |
| Pubmed | TRIO INPPL1 RNF19B CLHC1 LPIN1 FAT1 MIB1 PYGL NOL8 CUL4B DENND5B MRE11 COL12A1 SH3RF1 B3GALNT2 SAMD4B DIS3 TRIM33 PPP1R10 PPP2R1A INF2 RBM34 | 1.17e-06 | 689 | 335 | 22 | 36543142 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | NEB TUFM FASN EIF3L BTRC ARHGEF6 FBXW11 PRDX4 HEATR1 MKNK1 PPP2R1A TRAP1 IGF2BP2 VPS35 PRKAG1 PAK2 ELAVL1 | 1.25e-06 | 432 | 335 | 17 | 23455922 |
| Pubmed | INPPL1 COPB2 FASN FAM120A EIF3L PYGB POLR1B RAB5A PSAT1 PDCD6IP HSDL2 PRDX4 UPF1 DIS3 TRIM33 TRAP1 ATAD3B IGF2BP2 VPS35 | 1.33e-06 | 534 | 335 | 19 | 35032548 | |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | FASN PYGL PLS3 COL6A3 PDCD6IP UPF1 DIS3 TRIM33 TRAP1 THOP1 VPS35 | 1.48e-06 | 179 | 335 | 11 | 36261009 |
| Pubmed | DHX36 ATP6V1B2 DLG5 INPPL1 KIF1B ETF1 COPB2 TUFM TXN FASN FAM120A H4C1 NUFIP2 DDX54 RAB7A RAB13 FBXW11 TBX3 PSAT1 PDCD6IP PUF60 UPF1 DIS3 CYFIP2 PPP2R1A IGF2BP2 THOP1 INF2 SMARCA2 ELAVL1 TOP2A | 1.70e-06 | 1247 | 335 | 31 | 27684187 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | THNSL1 ETF1 EIF3L NUFIP2 SHPRH PYGL POLR1B ALDH3A2 UTRN BTRC WDR24 FBXW11 CUL4B MRE11 DYNC2H1 WDR70 DIS3 TFAP4 ATAD3B SND1 VPS35 SUPT16H SMARCA2 PRKAG1 KDM4A TNFAIP1 CRBN | 1.97e-06 | 1005 | 335 | 27 | 19615732 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MON2 DHX36 UGGT1 COPB2 HMGCR TUFM TXN FASN H4C1 UBE3A FDFT1 NUP210 PYGB AP1M1 PYGL POLR1B ALDH3A2 HSDL2 PRDX4 SHMT1 NOL11 UPF1 DIS3 PPP2R1A TRAP1 ATAD3B NAMPT SLC25A12 SND1 MTR ELAVL1 | 2.00e-06 | 1257 | 335 | 31 | 37317656 |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | DDX42 KRT80 TXN FAM120A H4C1 EIF3L NUFIP2 DDX54 RAB7A MRE11 PUF60 ATAD3B IGF2BP2 PBRM1 SND1 SUPT16H SMARCA2 ELAVL1 TOP2A RBM34 | 2.15e-06 | 605 | 335 | 20 | 28977666 |
| Pubmed | KIF21B ATP6V1B2 MYO5A UGGT1 DDX42 CD109 KRT80 H4C1 NUFIP2 POLR1B PLS3 MRE11 NOL11 LMNB2 HEATR1 UPF1 SND1 INF2 SUPT16H ELAVL1 TOP2A | 2.17e-06 | 660 | 335 | 21 | 32780723 | |
| Pubmed | DAB2IP MON2 DLGAP1 TRIO MYO5A COPB2 GGT7 TXN UBE3A SCN1A NUFIP2 PLCB1 RAB7A PYGB AP1M1 SIPA1L2 NOS1 BTRC MAPKAP1 PDCD6IP GRIA2 GSTM1 FRMD4A TRAP1 ATAD3B NAMPT TNFAIP1 CRYBG3 RAB21 | 2.35e-06 | 1139 | 335 | 29 | 36417873 | |
| Pubmed | 2.44e-06 | 89 | 335 | 8 | 24529757 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | ATP6V1B2 MYO5A DDX42 BCOR TXN UBE3A AP1M1 PYGL PDCD6IP PRDX4 UPF1 PPP1R10 PPP2R1A TRAP1 ATAD3B NAMPT SLC25A12 VPS35 SUPT16H ELAVL1 TOP2A | 2.45e-06 | 665 | 335 | 21 | 30457570 |
| Pubmed | HEXA UGGT1 COPB2 STK38 TUFM MYORG ITFG1 FASN COCH H4C1 FDFT1 NUP210 HSDL2 B3GALNT2 LEPR TRAP1 ATAD3B SLC25A12 TCTN2 SORL1 | 2.62e-06 | 613 | 335 | 20 | 22268729 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MYO5A COPB2 ABT1 DYSF FAM120A KLHL7 ATXN2 NUFIP2 POLR1B NOL8 MRE11 NOL11 UPF1 CYFIP2 PPP1R10 PPP2R1A IBTK TRAP1 ATAD3B IGF2BP2 SND1 PAK2 | 2.62e-06 | 724 | 335 | 22 | 36232890 |
| Pubmed | 2.63e-06 | 120 | 335 | 9 | 27320910 | ||
| Pubmed | TRIM65 regulates microRNA activity by ubiquitination of TNRC6. | DHX36 ZBTB24 GGT7 FAM120A ATXN2 NUFIP2 AP1M1 OBI1 LMNB2 UPF1 MSI1 SND1 TOP2A RBM34 SORL1 | 3.03e-06 | 364 | 335 | 15 | 24778252 |
| Interaction | SIRT7 interactions | DHX36 ATR MYO5A UGGT1 COPB2 DDX42 TUFM FASN FAM120A H4C1 NUP210 EIF3L NUFIP2 DDX54 PYGB PYGL UTRN CUL4B MRE11 PDCD6IP PUF60 PRDX4 NOL11 LMNB2 HEATR1 UPF1 PPARG DIS3 PPP2R1A IGF2BP2 PBRM1 SND1 SMARCA2 ELAVL1 TOP2A RBM34 | 7.43e-09 | 744 | 331 | 36 | int:SIRT7 |
| Interaction | EED interactions | DHX36 TRIO VPS13C UGGT1 ETF1 COPB2 DDX42 OBSCN STK38 BCOR TUFM TXN FASN H4C1 NUP210 EIF3L DDX54 SHPRH RAB7A AP1M1 NID1 RAB5A PLS3 BTRC VAV1 FBXW11 CUL4B MRE11 PSAT1 PDCD6IP PUF60 PRDX4 NOL11 LMNB2 HEATR1 UPF1 INTS8 DIS3 PPP2R1A IGF2BP2 THOP1 PBRM1 SLC25A12 SND1 VPS35 SUPT16H SMARCA2 PRKAG1 UBA6 PAK2 ELAVL1 TOP2A | 7.09e-08 | 1445 | 331 | 52 | int:EED |
| Interaction | CTAGE1 interactions | 2.73e-07 | 10 | 331 | 5 | int:CTAGE1 | |
| Interaction | CLEC16A interactions | MON2 DHX36 C3orf38 UGGT1 COPB2 COCH NUP210 DDX54 RAB7A POLR1B MTARC2 SIPA1L2 CUL4B MAPKAP1 AMD1 COG2 DYNC2H1 HEATR1 MSI1 MAP3K6 DIS3 TUBGCP6 TRAP1 SLC25A12 VPS35 MTR RAB21 | 5.88e-06 | 629 | 331 | 27 | int:CLEC16A |
| Interaction | PLS3 interactions | MYO5A LRRK2 LMTK3 DNAJB14 TUFM FASN ATXN2 PLS3 TRIM33 PPP2R1A TRAP1 THOP1 SND1 ELAVL1 EPHA7 | 9.49e-06 | 237 | 331 | 15 | int:PLS3 |
| Interaction | MTDH interactions | CD109 OBSCN NEB TUFM TMPRSS11B ITFG1 FASN RAB24 H4C1 NUP210 DDX54 RAB7A RAB5A BTRC CUL4B NPR1 ANPEP GRIA2 CYFIP2 SND1 SUPT16H TOP2A RBM34 | 1.15e-05 | 505 | 331 | 23 | int:MTDH |
| Interaction | MTSS1 interactions | 1.43e-05 | 33 | 331 | 6 | int:MTSS1 | |
| Interaction | LGALS9 interactions | ATP6V1B2 CD109 SLC7A11 TUFM TXN FASN H4C1 EIF3L RAB7A NID1 PYGL PLS3 PDCD6IP PRDX4 NOL11 HEATR1 UPF1 CNNM4 PPP2R1A ATAD3B SND1 VPS35 RAB21 TOP2A SORL1 | 1.54e-05 | 588 | 331 | 25 | int:LGALS9 |
| Interaction | NR2C2 interactions | DHX36 ETF1 TUFM RAB8A FASN FAM120A H4C1 KLHL7 FDFT1 EIF3L MIB1 DDX54 AP1M1 PYGL POLR1B PPIP5K2 TAF6 RAB5A RAB13 CUL4B MRE11 SH3RF1 PDCD6IP HSDL2 PUF60 PRDX4 NOL11 HEATR1 UPF1 DIS3 TRAP1 IGF2BP2 NAMPT PBRM1 SLC25A12 SND1 SUPT16H SMARCA2 PRKAG1 PAK2 ELAVL1 RAB21 TOP2A RBM34 | 2.71e-05 | 1403 | 331 | 44 | int:NR2C2 |
| Interaction | NUAK1 interactions | 2.89e-05 | 96 | 331 | 9 | int:NUAK1 | |
| Interaction | MCPH1 interactions | 4.33e-05 | 101 | 331 | 9 | int:MCPH1 | |
| Interaction | LINC01587 interactions | 4.70e-05 | 25 | 331 | 5 | int:LINC01587 | |
| Interaction | KCTD13 interactions | DHX36 DLGAP1 ATP6V1B2 TRIO MYO5A INPP4A KIF1B ETF1 COPB2 ALDH1L1 TUFM TXN FASN FAM120A SACS H4C1 SCN2A EIF3L NUFIP2 RAB7A PYGB PLCL1 SIPA1L2 DNAH6 NOS1 UTRN PLS3 PDCD6IP DPYSL4 GRIA2 UPF1 PPARG CYFIP2 PPP2R1A MLIP SLC25A12 P2RX3 SND1 INF2 VCAN VPS35 ELAVL1 TNFAIP1 | 4.96e-05 | 1394 | 331 | 43 | int:KCTD13 |
| Interaction | TDRD3 interactions | KIF1B FAM120A ATXN2 NUFIP2 MIB1 SAMD4B UPF1 CYFIP2 IBTK IGF2BP2 SND1 MTR ELAVL1 | 5.17e-05 | 212 | 331 | 13 | int:TDRD3 |
| Interaction | GDI1 interactions | HEXA DHX36 ALDH1L1 RAB8A RAB24 RAB7A RAB5A RAB13 DYNC2H1 PAK2 RAB21 | 5.25e-05 | 155 | 331 | 11 | int:GDI1 |
| Interaction | STIP1 interactions | ATP6V1B2 ETF1 COPB2 LRRK2 NEB DNAJB14 TUFM TXN FASN ATXN2 NUP210 EIF3L RAB7A AP1M1 ALDH3A2 PLS3 CUL4B MRE11 PDCD6IP PUF60 ANXA3 NOL11 LMNB2 HEATR1 UPF1 DIS3 TRIM33 PPP2R1A TRAP1 NAMPT SND1 VPS35 SUPT16H ELAVL1 | 5.71e-05 | 1006 | 331 | 34 | int:STIP1 |
| Interaction | ARHGAP24 interactions | COPB2 TUFM GGT7 H4C1 EIF3L MIB1 PYGB PYGL ARHGAP25 PLS3 CUL4B MRE11 PDCD6IP PUF60 WDR70 NOL11 DIS3 PPP2R1A ATAD3B SND1 VPS35 | 5.93e-05 | 486 | 331 | 21 | int:ARHGAP24 |
| Interaction | WDR5 interactions | ATP6V1B2 COPB2 ABT1 TUFM RAB8A TXN FASN H4C1 UBE3A FDFT1 EIF3L DDX54 TAF6 ALDH3A2 UTRN PLS3 CUL4B MAPKAP1 PDCD6IP HSDL2 PUF60 NOL11 LMNB2 HEATR1 UPF1 PARP14 TRAP1 ATAD3B IGF2BP2 VPS35 SUPT16H SMARCA2 RERE RAB21 EPAS1 RBM34 | 6.73e-05 | 1101 | 331 | 36 | int:WDR5 |
| Interaction | DYSF interactions | 6.86e-05 | 62 | 331 | 7 | int:DYSF | |
| Interaction | BIRC3 interactions | DHX36 ATR TRIO UGGT1 ETF1 COPB2 DDX42 TUFM TXN FASN H4C1 NUP210 EIF3L DDX54 RAB7A AP1M1 ALDH3A2 PLS3 MRE11 PSAT1 PDCD6IP HSDL2 DYNC2H1 PUF60 PRDX4 NOL11 LMNB2 HEATR1 UPF1 DIS3 CYFIP2 PPP2R1A TRAP1 NAMPT PBRM1 SND1 VPS35 SUPT16H UBA6 ELAVL1 TOP2A | 8.16e-05 | 1334 | 331 | 41 | int:BIRC3 |
| Interaction | ANKRD20A4P interactions | 8.46e-05 | 6 | 331 | 3 | int:ANKRD20A4P | |
| Interaction | LMBR1L interactions | GALNT1 SARM1 COPB2 DNAJB14 TUFM GGT7 FASN UBE3A FDFT1 NUP210 EIF3L NUFIP2 TIMELESS ALDH3A2 PDCD6IP HSDL2 DYNC2H1 LMNB2 HEATR1 UPF1 CLSTN1 INTS8 CNNM4 PPP2R1A ATAD3B SLC25A12 SND1 INF2 VPS35 MTR CERS1 TCTN2 | 9.36e-05 | 946 | 331 | 32 | int:LMBR1L |
| Interaction | RNF123 interactions | VPS13C COPB2 OBSCN ANKRD20A3P MAGEB6 DNAH14 TUFM JAK2 SAMD9L H4C1 SCN3A EIF3L SCN8A KCNS2 ANKRD18A PLCB3 MTARC2 UTRN BANK1 MRE11 PCDHA5 LMNB2 PARP14 MAP3K6 DIPK2B MIPOL1 INF2 ZNF277 TNFAIP1 | 1.02e-04 | 824 | 331 | 29 | int:RNF123 |
| Cytoband | 7q35 | 5.18e-05 | 55 | 335 | 5 | 7q35 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q35 | 1.25e-04 | 66 | 335 | 5 | chr7q35 | |
| Cytoband | 3p22-p21.3 | 3.15e-04 | 4 | 335 | 2 | 3p22-p21.3 | |
| GeneFamily | CTAGE family | 2.57e-08 | 15 | 244 | 6 | 907 | |
| GeneFamily | Cadherin related | 2.33e-06 | 17 | 244 | 5 | 24 | |
| GeneFamily | Glycogen phosphorylases | 2.43e-06 | 3 | 244 | 3 | 437 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 3.87e-06 | 9 | 244 | 4 | 1203 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 4.28e-06 | 19 | 244 | 5 | 832 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 2.41e-04 | 65 | 244 | 6 | 388 | |
| GeneFamily | Phospholipases | 2.43e-04 | 42 | 244 | 5 | 467 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 2.62e-04 | 66 | 244 | 6 | 722 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 1.07e-03 | 4 | 244 | 2 | 1244 | |
| GeneFamily | Dyneins, axonemal | 1.44e-03 | 17 | 244 | 3 | 536 | |
| GeneFamily | Ankyrin repeat domain containing | ANKRD20A2P ANKRD20A3P BCOR ANKRD18B ANKRD20A4P MIB1 ANKRD18A BANK1 ANKRD20A1 IBTK | 1.71e-03 | 242 | 244 | 10 | 403 |
| GeneFamily | Zinc fingers GRF-type|Topoisomerases | 3.64e-03 | 7 | 244 | 2 | 135 | |
| GeneFamily | Guanylate cyclase receptors | 3.64e-03 | 7 | 244 | 2 | 343 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | MON2 GALNT1 INPP4A DDX42 UBAP1 DHDDS HMGCR JAK2 SACS UBE3A FDFT1 NUP210 RAB7A PYGB TIMELESS RAB5A BANK1 NOL8 CUL4B AMD1 COG2 HSDL2 PRDX4 WDR70 SLC7A6 CYFIP2 TRIM33 PPP1R10 IBTK ZNF277 ELMO2 ASMTL AACS MTR PAK2 ELAVL1 KDM4A PLK4 SOS2 | 1.35e-07 | 1215 | 335 | 39 | M41122 |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | MYO5A UGGT1 SLC7A11 COL6A3 TBX3 COL12A1 SLC7A6 IGF2BP2 MCTP1 VCAN RERE CDH13 | 1.27e-06 | 162 | 335 | 12 | M45037 |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_UP | STK38 ANKRD20A3P ANKRD20A8P ANKRD18B FAM120A ANKRD20A4P ANKRD18A DNAH8 ANKRD20A1 DENND5B PUF60 PCDHB8 TSEN54 | 1.27e-06 | 192 | 335 | 13 | MM752 |
| Coexpression | GSE2706_2H_VS_8H_R848_STIM_DC_DN | C3orf38 SLC7A11 TXN JAK2 SAMD9L PDILT ARHGAP25 PSAT1 PCDHB11 OAS2 PARP14 TRIM5 UBA6 | 1.60e-06 | 196 | 335 | 13 | M4730 |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_UP | TTC39C INPPL1 SLC7A11 TIMELESS NNMT ANXA3 PRDX4 PCDHB11 PPARG CLSTN1 CNNM4 IGF2BP2 TLR1 | 2.00e-06 | 200 | 335 | 13 | M6655 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | DHX36 ATR TRIO TTC39C SYTL2 STK38 SLC7A11 KRT80 NLN PLCB1 NOL8 CUL4B MRE11 PSAT1 DYNC2H1 MIPOL1 IGF2BP2 NAMPT VCAN VPS35 SUPT16H UBA6 PAK2 PLK4 TOP2A RBM34 | 2.38e-06 | 721 | 335 | 26 | M10237 |
| Coexpression | GSE27786_ERYTHROBLAST_VS_NEUTROPHIL_DN | DHX36 RNF19B KRT80 ITFG1 NLN RAB24 PLCB3 SPG11 AAGAB SBNO1 SLFN13 TLR1 | 1.12e-05 | 200 | 335 | 12 | M4876 |
| Coexpression | GSE21546_WT_VS_SAP1A_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | COL6A5 SAMD9L MIB1 SHPRH BTRC WDR24 SHMT1 PARP14 MKNK1 SLFN13 UBA6 KDM4A | 1.12e-05 | 200 | 335 | 12 | M7532 |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | LAYN STK38 GGT7 COCH TIMELESS LAMA2 SHMT1 TFAP4 GSTM1 KLHDC8A | 2.06e-05 | 147 | 335 | 10 | M2387 |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_UP | KIF21B ATR MYO5A INPPL1 UGGT1 KIF1B RCBTB2 SLC7A11 NLN KIF9 SAMD9L DENND1B MIA2 ATXN2 SIPA1L2 UTRN CUL4B PSAT1 ANXA3 SAMD4B SPG11 GSTM1 TRAP1 NAMPT THOP1 ZNF277 SLFN13 HTT | 3.47e-05 | 942 | 335 | 28 | M8144 |
| Coexpression | NAKAMURA_ADIPOGENESIS_LATE_UP | 3.80e-05 | 98 | 335 | 8 | M2026 | |
| Coexpression | KATSANOU_ELAVL1_TARGETS_DN | LAYN STK38 GGT7 COCH TIMELESS LAMA2 SHMT1 TFAP4 GSTM1 KLHDC8A | 3.83e-05 | 158 | 335 | 10 | MM934 |
| Coexpression | GSE25677_MPL_VS_MPL_AND_R848_STIM_BCELL_UP | LRRK2 ZBTB24 BTRC PDCD6IP PARP14 ELMO2 PRKAG1 UBA6 RERE RAB21 | 4.26e-05 | 160 | 335 | 10 | M8183 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | DHX36 GALNT1 LAYN ATR MYO5A VPS13C DNAJB14 ITFG1 SACS UBE3A NID1 PPIP5K2 OBI1 PLS3 CUL4B SPG11 TRIM33 PBRM1 ABCA5 SMARCA2 MTR SORL1 | 4.30e-05 | 656 | 335 | 22 | M18979 |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | ZGRF1 ATXN2 PLCL1 BANK1 DYNC2H1 SHMT1 SLFN13 AACS PAK2 TNFAIP1 CRYBG3 | 5.48e-05 | 199 | 335 | 11 | M6987 |
| Coexpression | GSE15659_NAIVE_VS_PTPRC_NEG_CD4_TCELL_DN | ARHGAP42 SCN8A PYGL TBX3 S100A16 PRDX4 TSEN54 TLR1 VPS35 SYT14 UBA6 | 5.74e-05 | 200 | 335 | 11 | M3538 |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP | STK38 COCH SCN3A NUFIP2 KCNJ16 ARHGAP25 BANK1 SPG11 TRIM5 CYFIP2 KCTD18 | 5.74e-05 | 200 | 335 | 11 | M6477 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_DC_DN | HEXA TRIO STK38 ALDH3A2 VAV1 ARHGEF6 CLSTN1 SLC25A12 TLR1 HTT SORL1 | 5.74e-05 | 200 | 335 | 11 | M5204 |
| Coexpression | GSE22886_DAY0_VS_DAY1_MONOCYTE_IN_CULTURE_UP | ATR INPPL1 STK38 NUP210 PYGL ARHGAP25 BIN2 SELL INTS8 RERE SORL1 | 5.74e-05 | 200 | 335 | 11 | M4458 |
| Coexpression | GSE13762_CTRL_VS_125_VITAMIND_DAY12_DC_DN | 5.88e-05 | 134 | 335 | 9 | M1896 | |
| Coexpression | KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP | KIF21B MYO5A INPPL1 UGGT1 KIF1B RCBTB2 SLC7A11 SAMD9L DENND1B MIA2 ARHGAP25 BIN2 SIPA1L2 UTRN CUL4B PSAT1 ANXA3 SAMD4B SPG11 GSTM1 NAMPT ZNF277 SLFN13 HTT | 7.21e-05 | 778 | 335 | 24 | M17915 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP | GALNT1 MAP3K20 SLC7A11 DNAJB14 SAMD9L FAM120A MIB1 ANKRD20A1 ANXA3 TRIM5 NAMPT MCTP1 ZNF277 VPS35 CATSPERB TOP2A | 7.28e-05 | 404 | 335 | 16 | M19488 |
| Coexpression | LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE | PDE10A DNAH14 SCN2A KCNJ16 KIAA1958 PLCL1 SH3RF1 DYNC2H1 ABCA5 MTR RERE | 8.16e-05 | 208 | 335 | 11 | M39233 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | KIF21B ATR MYO5A INPP4A VPS13C TTC39C DNAJB14 LPIN1 SAMD9L DENND1B SACS UBE3A NUP210 NUFIP2 AP1M1 ARHGAP25 BIN2 UTRN VAV1 ARHGEF6 OAS2 SPG11 TSEN54 PARP14 SLC7A6 CYFIP2 EPG5 PCF11 TRIM33 SBNO1 ELMO2 SMARCA2 MTR PAK2 RAB21 CRBN SORL1 | 9.37e-05 | 1492 | 335 | 37 | M40023 |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_CD4_TCELL_UP | 9.48e-05 | 176 | 335 | 10 | M8881 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_UP | DLG5 UGGT1 HMGCR FASN FDFT1 UTRN TBX3 HEATR1 IGF2BP2 MTR RBM34 | 1.01e-04 | 213 | 335 | 11 | M14601 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | GALNT1 ATR TRIO DDX42 FAT1 MIA2 SACS ATXN2 UBE3A PPIP5K2 BTRC FBXW11 SPG11 TEAD1 PCF11 TRIM33 IBTK NAMPT SLC25A12 SMARCA2 MTR CRYBG3 RAB21 TOP2A SOS2 | 1.21e-04 | 856 | 335 | 25 | M4500 |
| Coexpression | GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP | KIF21B DHX36 GALNT1 STK38 KLHL7 UTRN VAV1 ANAPC4 PARP14 SBNO1 | 1.37e-04 | 184 | 335 | 10 | M9005 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 1.51e-04 | 40 | 335 | 5 | M5887 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | ATR MYO5A C3orf38 SAMD9L MIB1 RAB5A RAB13 ANAPC4 CUL4B MRE11 INTS8 IGF2BP2 NAMPT PBRM1 ZNF277 VPS35 CRBN RBM34 | 1.55e-04 | 523 | 335 | 18 | M12707 |
| Coexpression | GAO_LARGE_INTESTINE_24W_C8_GOBLET_CELL | 1.70e-04 | 41 | 335 | 5 | M39158 | |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP | 1.71e-04 | 154 | 335 | 9 | M19384 | |
| Coexpression | GSE41867_NAIVE_VS_DAY30_LCMV_CLONE13_EXHAUSTED_CD8_TCELL_UP | MASP1 C3orf38 KRT80 GRHL1 SAMD9L RAB24 PARP14 NAMPT MCTP1 VCAN | 1.93e-04 | 192 | 335 | 10 | M9509 |
| Coexpression | BOYAULT_LIVER_CANCER_SUBCLASS_G6_UP | 1.99e-04 | 66 | 335 | 6 | M4342 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_UP | ATR MYO5A C3orf38 SAMD9L MIB1 RAB5A RAB13 ANAPC4 CUL4B MRE11 INTS8 IGF2BP2 NAMPT PBRM1 ZNF277 VPS35 CRBN RBM34 | 2.00e-04 | 534 | 335 | 18 | MM1054 |
| Coexpression | YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP | 2.17e-04 | 159 | 335 | 9 | MM777 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_UP | DLG5 CFAP300 ASIC2 UGGT1 SLC7A11 HOXC4 SACS EIF3L PYGB TAF6 UTRN MMS22L LMNB2 HEATR1 SLC7A6 CLSTN1 DIPK2B IGF2BP2 MCTP1 VCAN AACS MTR RERE CDH13 TCTN2 | 2.23e-04 | 891 | 335 | 25 | M45033 |
| Coexpression | MURARO_PANCREAS_BETA_CELL | ATP6V1B2 MYO5A VPS13C RNF19B RCBTB2 TMCC3 LPIN1 FASN ATXN2 PLCB1 SIPA1L2 UTRN RAB5A DENND5B NPR2 WHAMM CYFIP2 ABCA5 SBNO1 ZNF277 ELMO2 KLHDC8A VPS35 AACS RERE SORL1 | 2.30e-04 | 946 | 335 | 26 | M39169 |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_DN | KIF21B KIF1B DENND1B NPR2 PCDHB11 PON3 SERPINA6 SBNO1 CDH9 HTT | 2.48e-04 | 198 | 335 | 10 | M5545 |
| Coexpression | GSE13485_PRE_VS_POST_YF17D_VACCINATION_PBMC_DN | SAMD9L KIAA1958 TIMELESS ALDH3A2 HSDL2 WDR70 OAS2 PARP14 TRIM5 VPS35 | 2.58e-04 | 199 | 335 | 10 | M3311 |
| Coexpression | GSE10240_IL17_VS_IL17_AND_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_DN | LAYN MAP3K20 LMTK3 ATXN2 SCN8A TIMELESS PLCL1 BTRC DYNC2H1 SLFN13 | 2.58e-04 | 199 | 335 | 10 | M312 |
| Coexpression | GSE16522_MEMORY_VS_NAIVE_ANTI_CD3CD28_STIM_CD8_TCELL_UP | GALNT1 ITFG1 LPIN1 ARHGAP25 PLS3 MAPKAP1 ANXA3 MKNK1 ELMO2 EPAS1 | 2.58e-04 | 199 | 335 | 10 | M3660 |
| Coexpression | GSE21546_ELK1_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_UP | 2.58e-04 | 199 | 335 | 10 | M7530 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_UP | RCBTB2 AP1M1 POLR1B TAF6 ALDH3A2 PUF60 LMNB2 PBRM1 INF2 RERE | 2.58e-04 | 199 | 335 | 10 | M7784 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_LOW_DOSE_MAC_DN | 2.58e-04 | 199 | 335 | 10 | M5240 | |
| Coexpression | GSE360_L_MAJOR_VS_T_GONDII_MAC_DN | 2.58e-04 | 199 | 335 | 10 | M5246 | |
| Coexpression | CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN | KIF1B SYTL2 LRRK2 LMTK3 ITFG1 GRHL1 FAT1 KIF9 MIA2 ALDH3A2 CTAGE9 PDCD6IP SHMT1 CLSTN1 TNFAIP1 | 2.65e-04 | 407 | 335 | 15 | M2214 |
| Coexpression | GSE5503_MLN_DC_VS_PLN_DC_ACTIVATED_ALLOGENIC_TCELL_DN | ZGRF1 FAM120A ATXN2 BANK1 DYNC2H1 SHMT1 PARP14 SLFN13 AACS UBA6 | 2.69e-04 | 200 | 335 | 10 | M291 |
| Coexpression | GSE27786_CD4_TCELL_VS_ERYTHTROBLAST_DN | 2.69e-04 | 200 | 335 | 10 | M4828 | |
| Coexpression | GSE26030_UNSTIM_VS_RESTIM_TH1_DAY5_POST_POLARIZATION_DN | ATP6V1B2 MYO5A TTC39C KIF9 ARHGEF6 SELL PRDX4 FRMD4A SLC25A12 INF2 | 2.69e-04 | 200 | 335 | 10 | M8568 |
| Coexpression | GSE32986_UNSTIM_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP | 2.69e-04 | 200 | 335 | 10 | M8608 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_DAY7_FLU_VACCINE_UP | 2.69e-04 | 200 | 335 | 10 | M4966 | |
| Coexpression | GSE21546_SAP1A_KO_VS_SAP1A_KO_AND_ELK1_KO_ANTI_CD3_STIM_DP_THYMOCYTES_DN | DAB2IP HEXA TRIO INPP4A UGGT1 ARHGAP25 VAV1 SHMT1 TNFAIP1 CRYBG3 | 2.69e-04 | 200 | 335 | 10 | M7526 |
| Coexpression | GSE21670_TGFB_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | GALNT1 MYO5A GRHL1 SCN1A COG2 PSAT1 TEAD1 CYFIP2 PPP2R1A KDM4A | 2.69e-04 | 200 | 335 | 10 | M7447 |
| Coexpression | GSE360_L_DONOVANI_VS_T_GONDII_MAC_DN | 2.69e-04 | 200 | 335 | 10 | M5234 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_UP | TTC16 INPP4A COPB2 MAP3K20 DHDDS GRHL1 PLCD1 SH3RF1 CYFIP2 P2RX3 | 2.69e-04 | 200 | 335 | 10 | M9000 |
| Coexpression | GSE17721_0.5H_VS_24H_CPG_BMDC_DN | RNF19B LRRK2 JAK2 PON3 PARP14 GSTM1 IGF2BP2 SLFN13 CRBN SOS2 | 2.69e-04 | 200 | 335 | 10 | M4129 |
| Coexpression | GSE19941_IL10_KO_VS_IL10_KO_AND_NFKBP50_KO_LPS_AND_IL10_STIM_MACROPHAGE_DN | 2.86e-04 | 165 | 335 | 9 | M8121 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | MON2 ARHGAP42 CFAP300 TRIO TTC39C INPPL1 KIF1B CYP39A1 DNAJB14 TMCC3 S100A1 JAK2 SAMD9L SLC13A4 SCN8A BTRC COL6A3 HSDL2 PCDHB8 SLC2A14 GRIA2 CYFIP2 SMARCA2 ELAVL1 KCTD18 HTT TCTN2 EPHA7 SORL1 | 2.90e-04 | 1124 | 335 | 29 | MM1070 |
| Coexpression | CUI_DEVELOPING_HEART_RIGHT_VENTRICULAR_CARDIOMYOCYTE | 3.14e-04 | 26 | 335 | 4 | M39314 | |
| Coexpression | FEVR_CTNNB1_TARGETS_DN | DHX36 ZGRF1 UBAP1 BCOR NUP210 EIF3L POLR1B TIMELESS MRE11 PRDX4 SHMT1 PPARG AAGAB DIS3 GSTM1 ZNF277 TOP2A SOS2 | 3.18e-04 | 555 | 335 | 18 | M2343 |
| Coexpression | GSE9946_LISTERIA_INF_MATURE_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_UP | 3.38e-04 | 134 | 335 | 8 | M430 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_DC1_CELL | LRRK2 MAP3K20 DENND1B NUP210 KIAA1958 NID1 PLCD1 ANPEP CYFIP2 SLC25A12 INF2 CRYBG3 QRSL1 | 3.39e-04 | 328 | 335 | 13 | M45723 |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#3_top-relative-expression-ranked_1000 | DLG5 TRABD2B COL6A5 PYGB PYGL PPIP5K2 NOS1 NPR2 COL12A1 ANPEP SERPINA6 IGF2BP2 ZNF277 PLD5 EPHA7 | 2.17e-05 | 270 | 328 | 15 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k3_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | ARHGAP42 DLG5 CYP4F8 LAYN VPS13C TTC39C PDE10A SLC7A11 S100A1 DENND1B SACS SCN2A PYGB NPR2 COL12A1 ANPEP HSDL2 TRIM5 CYFIP2 GSTM1 PCF11 IGF2BP2 SPACA1 ZNF277 MTR PLD5 MARVELD2 SMC1B EPHA7 | 2.24e-05 | 804 | 328 | 29 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | Myeloid Cells, DC.4+.Sp, CD11b CD45 CD4 CD11c CD8a, Spleen, avg-1 | TRIO MYO5A CDHR3 LRRK2 KRT80 JAK2 PTCHD1 KIF9 SCN3A KCNJ16 PYGL BANK1 ANPEP ANXA3 OAS2 GSAP MCTP1 TLR1 | 3.07e-05 | 382 | 328 | 18 | GSM538248_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | ARHGAP42 DLG5 CYP4F8 TRABD2B LAYN COL6A5 SLC7A11 S100A1 DENND1B PYGB PYGL NOS1 UTRN CUL4B NPR2 COL12A1 ANPEP HSDL2 TRIM5 CYFIP2 PCF11 IGF2BP2 SPACA1 ZNF277 MTR PLD5 MARVELD2 EPHA7 | 5.62e-05 | 803 | 328 | 28 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | ATR KIF1B ADGRV1 BCOR DENND1B FAM120A TGFBRAP1 POLR1B UTRN CUL4B DIP2B TRIM33 PBRM1 MARVELD2 CRYBG3 | 2.23e-11 | 193 | 335 | 15 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | ARHGAP42 MASP1 OBSCN FAT1 PLCB1 NID1 UTRN TBX3 LAMA2 PCDHA5 TEAD1 CDH6 | 1.87e-08 | 186 | 335 | 12 | 888e85a025bd982d36c910db0f5a3385b1ca3b28 |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | MON2 DLGAP1 SLC7A11 ATXN2 PLCB1 UTRN TBX3 WDR70 IGF2BP2 VCAN MTR RERE | 2.66e-08 | 192 | 335 | 12 | 916fbec1c7ab7969bda711886ac88e877e30c280 |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | MON2 DLGAP1 SLC7A11 ATXN2 PLCB1 UTRN TBX3 WDR70 IGF2BP2 VCAN MTR RERE | 2.82e-08 | 193 | 335 | 12 | e6a688bc834f845ff64dae1be64f073eec5091a1 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | ASIC2 LRRK2 HMGCR GDF10 SCN1A SCN2A ATP2C2 NOS1 GRIA2 CYFIP2 VCAN CDH13 | 3.95e-08 | 199 | 335 | 12 | 19a97e27a4758e794ce7246d295e112b47931a48 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L6_THEMIS_LINC00343|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DCHS2 SYTL2 DNAH14 PTCHD1 DNAH6 MLIP RGS6 MCTP1 CDH6 CDH9 CDH13 | 1.35e-07 | 181 | 335 | 11 | 9de2f2cc5f02e0ca599c9e0d2cb1e1e4b5aac112 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 MASP1 TRABD2B CDHR3 LRRK2 FAT1 XYLB IGF2BP2 CDH6 CDH9 EPHA7 | 1.78e-07 | 186 | 335 | 11 | f28d72b47624b69a580b4429e2be560a26898591 |
| ToppCell | Control-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | ANKRD20A2P FAT1 SIPA1L2 PLS3 TBX3 ANXA3 CRPPA RGS6 MARVELD2 EPAS1 CDH13 | 1.98e-07 | 188 | 335 | 11 | 88b3415e33db81726dd29c1f50c886e057af50a0 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | DLGAP1 TRABD2B CDHR3 FAT1 XYLB IGF2BP2 VCAN SYT14 CDH6 CDH9 EPHA7 | 2.09e-07 | 189 | 335 | 11 | 28b502611829e4a24caff2562545c7db97686099 |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l14|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-07 | 116 | 335 | 9 | f2bf9599040f43b5ea8724841d7b71c0a859c016 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CD109 DYSF TMCC3 BMP6 PLCB1 SIPA1L2 LEPR DIPK2B RGS6 MCTP1 EPAS1 | 2.58e-07 | 193 | 335 | 11 | e09387af84d2a0a526e54d4793e6e06c6739db53 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CD109 DYSF TMCC3 BMP6 PLCB1 LEPR DIPK2B IGF2BP2 RGS6 MCTP1 EPAS1 | 2.58e-07 | 193 | 335 | 11 | 6e1982d089a9de628e6006d23ff78a223fbd9f47 |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DYSF TMCC3 BMP6 PLCB1 SIPA1L2 LEPR DIPK2B IGF2BP2 RGS6 MCTP1 EPAS1 | 2.71e-07 | 194 | 335 | 11 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT-L6_CT_ALM_Cpa6|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | TRABD2B OBSCN KRT80 SAMD9L ARHGAP25 COL12A1 IGF2BP2 MCTP1 INF2 CDH9 | 2.73e-07 | 154 | 335 | 10 | 12cbc38bc1f7231c67e1d2d5e86e95bc12e24682 |
| ToppCell | mild-Myeloid-Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | LRRK2 DYSF SAMD9L PYGL SIPA1L2 SELL ANXA3 OAS2 PARP14 NAMPT TLR1 | 3.01e-07 | 196 | 335 | 11 | e9f30eb8a3915c3b2af009c832bff9b349b65ae5 |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DLGAP1 ASIC2 UBE3A SCN1A SCN2A SCN3A SCN8A PLCB1 GRIA2 FRMD4A ABCA5 | 3.33e-07 | 198 | 335 | 11 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DLGAP1 ASIC2 UBE3A SCN1A SCN2A SCN3A SCN8A PLCB1 GRIA2 FRMD4A ABCA5 | 3.33e-07 | 198 | 335 | 11 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-neutrophil|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | ATP6V1B2 ETF1 LRRK2 DYSF TXN PYGL BIN2 SELL ANXA3 NAMPT SORL1 | 3.50e-07 | 199 | 335 | 11 | 86f2857ce60fbe59375411373ff49c684fd66ad0 |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | ARHGAP42 MASP1 SYTL2 OBSCN FAT1 PLCB1 NID1 TBX3 LAMA2 TEAD1 CDH6 | 3.68e-07 | 200 | 335 | 11 | 0c648941447c738caf62f2d71e296d6cca492c8b |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | ARHGAP42 MASP1 SYTL2 OBSCN FAT1 PLCB1 NID1 TBX3 LAMA2 TEAD1 CDH6 | 3.68e-07 | 200 | 335 | 11 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | ARHGAP42 MASP1 SYTL2 OBSCN FAT1 PLCB1 NID1 TBX3 LAMA2 TEAD1 CDH6 | 3.68e-07 | 200 | 335 | 11 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 |
| ToppCell | severe-Myeloid-Neutrophils_4|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | KIF1B DYSF PYGL SELL ANPEP ANXA3 MKNK1 NAMPT TLR1 SORL1 SOS2 | 3.68e-07 | 200 | 335 | 11 | b665f36dcf3c9d3981ee96f2973512f751612542 |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | DAB2IP ARHGAP42 SYTL2 FAT1 PLCB1 COL12A1 RGS6 PLD5 CDH6 CDH13 | 8.40e-07 | 174 | 335 | 10 | 015d3742d3d79a57413a333f00ef2d380a9848dd |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)-Glut_CT_L6_FEZF2-Exc_L5-6_FEZF2_ANKRD20A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DCHS2 ASIC2 ANKRD20A4P ATP2C2 ANKRD18A ARHGAP25 ANKRD20A1 TEAD1 CRYBG3 CDH6 | 8.40e-07 | 174 | 335 | 10 | 99eb5e1aee136c7039e23b68a43a0fa3d775859f |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ANKRD20A4P SCN3A PYGM DNAH8 UTRN NPR1 FRMD4A RGS6 EPAS1 CDH13 | 8.85e-07 | 175 | 335 | 10 | 316f2ea930437bf1243b1c0f45e6bd864112c6f2 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | ANKRD20A4P SCN3A PYGM DNAH8 UTRN NPR1 FRMD4A RGS6 EPAS1 CDH13 | 8.85e-07 | 175 | 335 | 10 | a9f08e1e4c2997dcdd3e5d92daac480da19100b8 |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.81e-07 | 177 | 335 | 10 | 73ba0f0b4b33f10e9f036d6d9befa48a1258e682 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DLG5 SYTL2 PLEKHS1 ADGRV1 GRHL1 ATP2C2 UPF1 UBA6 CATSPERB SORL1 | 1.09e-06 | 179 | 335 | 10 | 6e965e424eebef50f0202cff75f458be395cfca1 |
| ToppCell | COVID-19-kidney-PCT-S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | DLGAP1 TRABD2B CDHR3 ALDH1L1 FAT1 KCNJ16 ANPEP CDH6 CDH9 EPHA7 | 1.14e-06 | 180 | 335 | 10 | 358923e4228035a3e90e2957392089219e90dcd7 |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | DLGAP1 TRABD2B CDHR3 ALDH1L1 FAT1 KCNJ16 ANPEP CDH6 CDH9 EPHA7 | 1.14e-06 | 180 | 335 | 10 | 864c895b5eaedefae86f5829fa344f7b686fb59f |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGAP42 ALLC SYTL2 FAT1 NID1 PLCL1 COL6A3 LAMA2 FRMD4A CDH6 | 1.40e-06 | 184 | 335 | 10 | 102b6f621a5b551e622f97b12d787c080b052a72 |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 1.40e-06 | 184 | 335 | 10 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.49e-06 | 107 | 335 | 8 | fc07dd90f280191bd643398eac5c8273651d0925 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 DLGAP1 TRABD2B CDHR3 LRRK2 FAT1 MIA2 ANPEP CDH6 EPHA7 | 1.62e-06 | 187 | 335 | 10 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | SYTL2 SCN2A SCN3A KCNJ16 PLCB1 PLCD1 NOS1 ANXA3 IGF2BP2 ABCA5 | 1.62e-06 | 187 | 335 | 10 | 77886f99c229610abd28c4c370d2c7d1536c9782 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.69e-06 | 188 | 335 | 10 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TRABD2B LRRK2 ADGRV1 DNAH14 PLCB1 NNMT IGF2BP2 CDH6 CDH9 EPHA7 | 1.69e-06 | 188 | 335 | 10 | af740fa78542438fdff627ea1f74f4eee43316be |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | ARHGAP42 DLGAP1 TRABD2B CDHR3 FAT1 MIA2 XYLB ANPEP CDH6 EPHA7 | 1.78e-06 | 189 | 335 | 10 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | ARHGAP42 DLGAP1 TRABD2B CDHR3 XYLB ANPEP IGF2BP2 CDH6 CDH9 EPHA7 | 1.86e-06 | 190 | 335 | 10 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | CD109 ANKRD20A2P TMCC3 BMP6 FAT1 ANKRD20A4P TBX3 LAMA2 LEPR EPAS1 | 1.86e-06 | 190 | 335 | 10 | 7f3f419fffe02934b6f27b697f7a6401072491ed |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.86e-06 | 190 | 335 | 10 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CD109 DYSF TMCC3 SIPA1L2 TBX3 DIPK2B IGF2BP2 RGS6 MCTP1 EPAS1 | 2.05e-06 | 192 | 335 | 10 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | CD109 DYSF TMCC3 SIPA1L2 TBX3 DIPK2B IGF2BP2 RGS6 MCTP1 EPAS1 | 2.05e-06 | 192 | 335 | 10 | 04f5a2e3dd6beff027b89d66eefdd92036e041af |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | PDE10A PLCB1 NID1 NNMT COL6A3 COL12A1 DYNC2H1 LAMA2 VCAN CATSPERB | 2.05e-06 | 192 | 335 | 10 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | LPS_only-Endothelial-Endothelial-Gen_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.15e-06 | 193 | 335 | 10 | af5108260783e69a7d67896c5bf64f862525926d | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | DLGAP1 DLG5 DNAH14 SCN8A PLCB1 KIAA1958 XYLB DENND5B TBX3 IGF2BP2 | 2.15e-06 | 193 | 335 | 10 | 503a979328c68b096680b71359a26f02fafdff35 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | TRABD2B ALDH1L1 DNAH14 FAT1 KCNJ16 KIAA1958 SH3RF1 CYFIP2 IGF2BP2 MTR | 2.15e-06 | 193 | 335 | 10 | 3866667dd221612589ae50f5c52f73a183a49ce6 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | DLGAP1 TRABD2B DNAH14 FAT1 KCNJ16 KIAA1958 SH3RF1 TEAD1 IGF2BP2 CDH6 | 2.25e-06 | 194 | 335 | 10 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.35e-06 | 195 | 335 | 10 | 6bdef651cf73d7381e5012d0eb3c809138fb6b92 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | SLC9C1 PLCB1 UTRN ANXA3 PPARG PARP14 DIPK2B MCTP1 EPAS1 CDH13 | 2.35e-06 | 195 | 335 | 10 | 50a193475db1bb1e05b8590225a553688c372c14 |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DLGAP1 ASIC2 UBE3A SCN2A SCN3A SCN8A PLCB1 GRIA2 FRMD4A ABCA5 | 2.46e-06 | 196 | 335 | 10 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 |
| ToppCell | Striatum-Neuronal-Excitatory|Striatum / BrainAtlas - Mouse McCarroll V32 | PDE10A PTCHD1 SCN2A SCN3A PLCB1 KCNS2 GRIA2 SBNO1 CDH9 EPHA7 | 2.46e-06 | 196 | 335 | 10 | 67400193ba469cf4d939e94f5ed94995e384bc07 |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.58e-06 | 197 | 335 | 10 | 7a1a3839b2c965136663241b0d4e96c64cfb656a | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DLGAP1 UBE3A SCN1A SCN2A SCN3A SCN8A PLCB1 GRIA2 FRMD4A ABCA5 | 2.70e-06 | 198 | 335 | 10 | c01091ef18e096d792ea2a7a715764a5b215355f |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | DLGAP1 ASIC2 UBE3A SCN2A SCN3A SCN8A PLCB1 GRIA2 FRMD4A ABCA5 | 2.70e-06 | 198 | 335 | 10 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 2.82e-06 | 199 | 335 | 10 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | severe|World / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.82e-06 | 199 | 335 | 10 | c24aacef7405700bc5d0b736a38feea12b7f17c8 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L6_CT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | TRABD2B OBSCN KRT80 ARHGAP25 COL12A1 IGF2BP2 MCTP1 INF2 CDH9 | 2.89e-06 | 156 | 335 | 9 | fe383ce3a0c37f7343d7026cb51260a04d4c2829 |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 2.95e-06 | 200 | 335 | 10 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | LPS_IL1RA|World / Treatment groups by lineage, cell group, cell type | ETF1 HMGCR JAK2 SIPA1L2 RAB13 COL12A1 IGF2BP2 MCTP1 PAK2 EPAS1 | 2.95e-06 | 200 | 335 | 10 | a02fa5b3c4723a6eaa3c685588666c710478dd25 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | KIF21B DLG5 INPP4A SYTL2 SAMD9L ARHGAP25 UTRN OAS2 CYFIP2 SLFN13 | 2.95e-06 | 200 | 335 | 10 | 2281debd86e5d92e8fe0397aec9ef670800f7471 |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.38e-06 | 159 | 335 | 9 | 95834b767cfb4fb8c5aeea89c10f3e14a1fd15c1 | |
| ToppCell | Bronchial_Brush-Epithelial-Goblet_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 3.38e-06 | 159 | 335 | 9 | a8fa49dc2e6ad726d1f4f2b30693fecd1151a485 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Calb2_Pdlim5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.55e-06 | 160 | 335 | 9 | dd16ca90feb3ae88b6409d6c278b4765da565514 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.29e-06 | 168 | 335 | 9 | d69452e2cfeb74023b5cf3d09064d7dcad0008ec | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.56e-06 | 169 | 335 | 9 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 6.11e-06 | 171 | 335 | 9 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-06 | 172 | 335 | 9 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 6.41e-06 | 172 | 335 | 9 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.41e-06 | 172 | 335 | 9 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 7.04e-06 | 174 | 335 | 9 | eaaf17a06efc09ed4752b449827b1f0f424d3dad | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-B_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 7.37e-06 | 175 | 335 | 9 | 69ed3c7c45df6bef70f5f2ff003531160bf3b32b | |
| ToppCell | PBMC-Convalescent-Lymphocyte-B-B_cell-B_naive-B_activate-7|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.72e-06 | 176 | 335 | 9 | dde46f06f6fc3f7ba83be91a0ee6231790955e3e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.08e-06 | 177 | 335 | 9 | bd602db857f37869ef76d14c05ef522c509f08ee | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.45e-06 | 178 | 335 | 9 | 23a12d3d971b857d5be8e907334d1f6b49eeeb32 | |
| ToppCell | TCGA-Peripheral_Nervous_System-Primary_Tumor-Paraganglioma-Paraganglioma-3|TCGA-Peripheral_Nervous_System / Sample_Type by Project: Shred V9 | 8.48e-06 | 135 | 335 | 8 | ac20133d4a36f48338b45bffb13e842cb66f83ad | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.84e-06 | 179 | 335 | 9 | 1ac79c82c52fa95bb4e170ab20fec0f648db2134 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 8.84e-06 | 179 | 335 | 9 | 58ae5a97fe2a14e1c6fdeb886397eb06fdaf0428 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_A_(CT)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.25e-06 | 180 | 335 | 9 | e8841ef1239f9ee73ac4f4e11faca0742694f368 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 9.67e-06 | 181 | 335 | 9 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-06 | 181 | 335 | 9 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-06 | 181 | 335 | 9 | aa233b652921848af2257cc3687a7a09c3acfb67 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.67e-06 | 181 | 335 | 9 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 1.01e-05 | 182 | 335 | 9 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-05 | 182 | 335 | 9 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.06e-05 | 183 | 335 | 9 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | LA-11._Adipocyte|LA / Chamber and Cluster_Paper | 1.06e-05 | 183 | 335 | 9 | 3f9011976782fa8aa95cdd6f00f07a91094d411b | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_vein-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.06e-05 | 183 | 335 | 9 | c1297d8eddfc7132e84ceef14f01b6281f9d0f6a | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 184 | 335 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.10e-05 | 184 | 335 | 9 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.10e-05 | 184 | 335 | 9 | d2bf0135eb56bb410997dccea39c5ede88a0617f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 184 | 335 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | COPD-Myeloid-cMonocyte|World / Disease state, Lineage and Cell class | 1.10e-05 | 184 | 335 | 9 | ceec41ed5636032aaf7716d1203816ea58bd39bd | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-05 | 184 | 335 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 1.10e-05 | 184 | 335 | 9 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 1.15e-05 | 185 | 335 | 9 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | pdx-Tumor_cells-T0|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.15e-05 | 185 | 335 | 9 | 1d874608aa2062024323512f68889219471b2f00 | |
| ToppCell | Control-Endothelial-VE_Capillary_A|World / Disease state, Lineage and Cell class | ANKRD20A2P ANKRD20A3P PLS3 TBX3 ANXA3 CRPPA DIPK2B EPAS1 CDH13 | 1.15e-05 | 185 | 335 | 9 | a28187c2fd23564314b35759479ff2ca21f61485 |
| ToppCell | Myeloid-B_(Activated_Macrophage)|World / shred on cell class and cell subclass (v4) | 1.20e-05 | 186 | 335 | 9 | 33d731a7883d75e4e7db83b641cdb1e9a39938bf | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.20e-05 | 186 | 335 | 9 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| Drug | PF-00562151-00 [351320-12-2]; Up 200; 10uM; PC3; HT_HG-U133A | TRIO INPP4A SARM1 SYTL2 BCOR HOXC4 PLCB3 CUL4B OAS2 PBRM1 MCTP1 ZNF277 SMARCA2 SOS2 | 1.20e-06 | 197 | 330 | 14 | 6863_UP |
| Drug | alpha-(fluoromethyl)dehydroornithine | 1.47e-06 | 7 | 330 | 4 | CID006439607 | |
| Drug | 3,5-dimethylphenyl isocyanate | 3.02e-06 | 3 | 330 | 3 | CID000521488 | |
| Drug | 5'-deoxy-5'-fluoro-5'-(methylthio)adenosine | 3.02e-06 | 3 | 330 | 3 | CID000147839 | |
| Drug | NSC758405 | 3.02e-06 | 3 | 330 | 3 | CID000003201 | |
| Drug | 3,5-dinitrophenyl phosphate | 3.02e-06 | 3 | 330 | 3 | CID000151920 | |
| Drug | pyridoxal phosphoglucose | 3.02e-06 | 3 | 330 | 3 | CID000196007 | |
| Drug | 5-ethyl-4-hydroxy-2-methyl-3(2H)-furanone | 3.02e-06 | 3 | 330 | 3 | CID000093111 | |
| Drug | adenosine-5'-chloromethylphosphonate | 3.02e-06 | 3 | 330 | 3 | CID000191554 | |
| Drug | hydan | 3.02e-06 | 3 | 330 | 3 | CID000008360 | |
| Drug | EHMF | 3.02e-06 | 3 | 330 | 3 | CID000033931 | |
| Drug | pyridoxal 5'-methylenephosphonate | 3.02e-06 | 3 | 330 | 3 | CID003082249 | |
| Drug | Plp 5'-mpa | 3.02e-06 | 3 | 330 | 3 | CID003082151 | |
| Drug | glucose-1,2-cyclic phosphate | 3.02e-06 | 3 | 330 | 3 | CID000191723 | |
| Drug | 3'-FFdUrd | 3.02e-06 | 3 | 330 | 3 | CID000072260 | |
| Drug | 2',3',4',5,5'-pentachloro-2-biphenylol | 3.02e-06 | 3 | 330 | 3 | CID000119518 | |
| Drug | AC1L8XK3 | 3.02e-06 | 3 | 330 | 3 | CID000409735 | |
| Drug | N-acetyl-N'-beta-D-glucopyranosyl urea | 3.02e-06 | 3 | 330 | 3 | CID000446801 | |
| Drug | riboflavin tetraacetate | 3.02e-06 | 3 | 330 | 3 | CID000094186 | |
| Drug | 2,5-dimethyl-3-furanone | 3.02e-06 | 3 | 330 | 3 | CID000085730 | |
| Drug | 3,5-dinitrophenol | 3.02e-06 | 3 | 330 | 3 | CID000011459 | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Up 200; 9.6uM; MCF7; HT_HG-U133A | ASIC2 SLC7A11 PLCD1 NNMT BTRC TBX3 OAS2 AAGAB DIS3 LEPR PKD2L2 VCAN SOS2 | 5.21e-06 | 193 | 330 | 13 | 2209_UP |
| Drug | SR-95639A [115767-94-7]; Up 200; 10uM; MCF7; HT_HG-U133A | KIF21B DLG5 PLEKHS1 SLC7A11 NID1 NPR2 DYNC2H1 AAGAB LEPR SMARCA2 TNFAIP1 RERE SOS2 | 6.88e-06 | 198 | 330 | 13 | 4977_UP |
| Drug | Tracazolate hydrochloride [41094-88-6]; Down 200; 11.8uM; MCF7; HT_HG-U133A | PDE4A TRIO JAK2 PLCB3 ALDH3A2 SHMT1 LMNB2 GSAP SLC7A6 DIS3 ELMO2 PLK4 SOS2 | 6.88e-06 | 198 | 330 | 13 | 4964_DN |
| Drug | nordihydroguaiaretic acid; Up 200; 1uM; HL60; HT_HG-U133A | SYTL2 ALDH1L1 PYGB ARHGAP25 PLCD1 NOS1 UTRN FBXW11 DPH1 NPR2 PLK4 TCTN2 SOS2 | 7.67e-06 | 200 | 330 | 13 | 1164_UP |
| Drug | Triton X-100 solution | MON2 SPAM1 ITFG1 PLCB1 PLCB3 RAB5A PLCZ1 ANPEP AAGAB THOP1 SPACA1 | 1.10e-05 | 148 | 330 | 11 | CID000560774 |
| Drug | galocitabine | 1.19e-05 | 4 | 330 | 3 | CID000065950 | |
| Drug | 5-deoxyribose-1-phosphate | 1.19e-05 | 4 | 330 | 3 | CID000135786 | |
| Drug | ingliforib | 1.19e-05 | 4 | 330 | 3 | CID006451325 | |
| Drug | uric acid riboside | 1.19e-05 | 4 | 330 | 3 | CID000164933 | |
| Drug | pseudo-dl-glucose | 1.19e-05 | 4 | 330 | 3 | CID000125259 | |
| Drug | pyridoxal diphosphate | 1.19e-05 | 4 | 330 | 3 | CID000125696 | |
| Drug | 2,5-anhydro-D-mannitol 1-phosphate | 1.19e-05 | 4 | 330 | 3 | CID000189134 | |
| Drug | AC1LAMW2 | 1.19e-05 | 4 | 330 | 3 | CID000491364 | |
| Drug | FdUrd-C8 | 1.19e-05 | 4 | 330 | 3 | CID000094262 | |
| Drug | Mem-CC | 1.19e-05 | 4 | 330 | 3 | CID003081269 | |
| Drug | BCIp4A | 1.19e-05 | 4 | 330 | 3 | CID000192417 | |
| Drug | 3'-chloromethotrexate | 1.19e-05 | 4 | 330 | 3 | CID000097703 | |
| Drug | milrinone | PDE4A PDE10A ATP2C2 PLCB1 PLCB3 PLCD1 NOS1 PLCZ1 NPR1 NPR2 ANXA3 | 1.25e-05 | 150 | 330 | 11 | CID000004197 |
| Drug | AC1L19D1 | 1.96e-05 | 12 | 330 | 4 | CID000000494 | |
| Drug | Air Pollutants, Occupational | ATP6V1B2 RNF19B COPB2 LRRK2 STK38 RCBTB2 ANKRD20A8P JAK2 NLN BMP6 SAMD9L RAB7A POLR1B ARHGAP25 VAV1 COG2 ANPEP WHAMM OAS2 GSTM1 PPP1R10 NAMPT RGS6 TLR1 VPS35 TNFAIP1 | 2.31e-05 | 725 | 330 | 26 | ctd:D000395 |
| Drug | Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A | ALLC INPP4A RNF19B HMGCR SLC7A11 LPIN1 KATNIP ALDH3A2 DYNC2H1 PCDHA5 PPP2R1A SND1 | 2.41e-05 | 191 | 330 | 12 | 7417_UP |
| Drug | hydroxyl radicals | HEXA KIF21B ALLC ATP6V1B2 CYP4F8 PDE4A INPP4A INPPL1 HMGCR ALDH1L1 PDE10A CYP39A1 TUFM GGT7 TXN FASN SAG FDFT1 ATP2C2 PLCB1 TIMELESS PLCB3 PLCD1 PLCL1 ALDH3A2 NNMT NOS1 ANAPC4 PLCZ1 COL6A3 ANPEP ANXA3 PRDX4 SHMT1 PON3 GSTM1 PPP2R1A MTR PAK2 | 2.81e-05 | 1341 | 330 | 39 | CID000000961 |
| Drug | pyridoxal | 2.84e-05 | 135 | 330 | 10 | CID000001050 | |
| Drug | heptulose-2-P | 2.95e-05 | 5 | 330 | 3 | CID000124823 | |
| Drug | 6-FPLP | 2.95e-05 | 5 | 330 | 3 | CID000146246 | |
| Drug | gluconohydroximo-1,5-lactone | 2.95e-05 | 5 | 330 | 3 | CID009576855 | |
| Drug | DHPBU | 2.95e-05 | 5 | 330 | 3 | CID000125914 | |
| Drug | 5'-isobutylthioinosine | 2.95e-05 | 5 | 330 | 3 | CID003080910 | |
| Drug | indirubin-5-sulphonate | 2.95e-05 | 5 | 330 | 3 | CID005288641 | |
| Drug | AC1LCUXJ | 2.95e-05 | 5 | 330 | 3 | CID000656425 | |
| Drug | 6-amino-5-bromouracil | 2.95e-05 | 5 | 330 | 3 | CID000080578 | |
| Drug | etafenone | 2.95e-05 | 5 | 330 | 3 | CID000003275 | |
| Drug | ddEtUrd | 2.95e-05 | 5 | 330 | 3 | CID000451452 | |
| Drug | 5-trifluoromethyl-2'-deoxycytidine | 2.95e-05 | 5 | 330 | 3 | CID000125618 | |
| Drug | m-anisidine | 2.95e-05 | 5 | 330 | 3 | CID000010824 | |
| Drug | 2-hydroxypropylphosphonate | 2.95e-05 | 5 | 330 | 3 | CID000441028 | |
| Drug | 6-FDPL | 2.95e-05 | 5 | 330 | 3 | CID000129578 | |
| Drug | 3'-O-methylpyridoxal 5'-phosphate | 2.95e-05 | 5 | 330 | 3 | CID003082179 | |
| Drug | GlcMan | 2.95e-05 | 5 | 330 | 3 | CID000152120 | |
| Drug | U66985 | 2.95e-05 | 5 | 330 | 3 | CID000127224 | |
| Drug | AC1O3M08 | 2.95e-05 | 5 | 330 | 3 | CID006331955 | |
| Drug | Riluzole hydrochloride; Up 200; 14.8uM; PC3; HT_HG-U133A | SARM1 DUS2 BMP6 ATP2C2 PLCB1 XYLB NOS1 BTRC DPH1 SHMT1 SMARCA2 SOS2 | 3.26e-05 | 197 | 330 | 12 | 7365_UP |
| Drug | copper(II) sulfate pentahydrate; Down 200; 100uM; MCF7; HG-U133A | ALLC MASP1 S100A1 DUS2 NUP210 PLCD1 NOS1 NPR2 UPF1 PPARG ZNF277 ELMO2 | 3.26e-05 | 197 | 330 | 12 | 438_DN |
| Drug | Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A | MON2 SPAM1 RCBTB2 PYGB XYLB NPR1 DYNC2H1 OAS2 GSAP GRM6 AAGAB ELMO2 | 3.60e-05 | 199 | 330 | 12 | 5471_UP |
| Drug | Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A | INPP4A NUP210 PLCD1 HSDL2 LMNB2 DIS3 THOP1 SND1 ELMO2 VCAN SMARCA2 UBA6 | 3.60e-05 | 199 | 330 | 12 | 4649_DN |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; HL60; HT_HG-U133A | MON2 PDE4A KATNIP PLCD1 UTRN BTRC FBXW11 ANXA3 OAS2 UPF1 EPAS1 SOS2 | 3.79e-05 | 200 | 330 | 12 | 6150_DN |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; PC3; HT_HG-U133A | MON2 PDE4A NNMT UTRN BTRC SELL PCDHA5 AAGAB TLR1 SMARCA2 CDH6 SOS2 | 3.79e-05 | 200 | 330 | 12 | 6701_UP |
| Drug | AC1MP21W | 3.87e-05 | 14 | 330 | 4 | CID003378340 | |
| Drug | guanine | DAB2IP MON2 DHX36 MASP1 IGFN1 TRIO ETF1 TUFM SAG PLCB1 PLCB3 PLCD1 RAB5A VAV1 ARHGEF6 ANAPC4 SELL PLCZ1 NPR1 HTR1B ARHGEF5 SHMT1 GRIA2 GRM6 RGS6 P2RX3 RAB21 HTT SOS2 | 5.70e-05 | 902 | 330 | 29 | CID000000764 |
| Drug | CV-araU | 5.84e-05 | 6 | 330 | 3 | CID006441877 | |
| Drug | 2-thiothymidine | 5.84e-05 | 6 | 330 | 3 | CID003005944 | |
| Drug | APETx1, Anthopleura elegantissima | 5.84e-05 | 6 | 330 | 3 | ctd:C475726 | |
| Drug | Carbocyclic Bvdc | 5.84e-05 | 6 | 330 | 3 | CID006438602 | |
| Drug | 2,2-dimethyl-3-hydroxybutyric acid | 5.84e-05 | 6 | 330 | 3 | CID000152984 | |
| Drug | EdUMP | 5.84e-05 | 6 | 330 | 3 | CID003085112 | |
| Drug | 5'-deoxy-5'-chloroformycin | 5.84e-05 | 6 | 330 | 3 | CID000126430 | |
| Drug | 5-n-propylthioadenosine | 5.84e-05 | 6 | 330 | 3 | CID000656428 | |
| Drug | AzddCyd | 5.84e-05 | 6 | 330 | 3 | CID000451374 | |
| Drug | 5-Ffdru | 5.84e-05 | 6 | 330 | 3 | CID000065561 | |
| Drug | Carbocyclic Ivdu | 5.84e-05 | 6 | 330 | 3 | CID006439191 | |
| Drug | DNPP | 5.84e-05 | 6 | 330 | 3 | CID000067056 | |
| Drug | 5-chloro-indole-2-carboxylic acid | 5.84e-05 | 6 | 330 | 3 | CID000082693 | |
| Drug | NSC-97433 | 5.84e-05 | 6 | 330 | 3 | CID000001803 | |
| Drug | AR-L57 | 5.84e-05 | 6 | 330 | 3 | CID000156890 | |
| Drug | 2'-fucosyllactose | 6.57e-05 | 30 | 330 | 5 | CID000170484 | |
| Drug | AC1L9LT0 | 7.83e-05 | 123 | 330 | 9 | CID000448294 | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | MASP1 THNSL1 PLCB1 LAMA2 TEAD1 GRM6 TRIM33 MCTP1 PBOV1 RERE CDH6 | 9.03e-05 | 186 | 330 | 11 | 4463_UP |
| Drug | NADP(H | CYP4F8 HMGCR ALDH1L1 CYP39A1 TXN FASN FDFT1 PYGB PYGL TIMELESS XYLB ALDH3A2 NOS1 NPR1 ANPEP SHMT1 GSTM1 PBRM1 SLC25A12 MTR | 9.64e-05 | 527 | 330 | 20 | CID000000930 |
| Drug | 6-fluoropyridoxal | 1.01e-04 | 7 | 330 | 3 | CID003080803 | |
| Drug | 3-methylcytidine | 1.01e-04 | 7 | 330 | 3 | CID000159649 | |
| Drug | AC1L3372 | 1.01e-04 | 7 | 330 | 3 | CID000108025 | |
| Drug | 1 Gpt | 1.01e-04 | 7 | 330 | 3 | CID000101247 | |
| Drug | formycins | 1.01e-04 | 7 | 330 | 3 | CID000512867 | |
| Drug | 5'-methylthioinosine | 1.01e-04 | 7 | 330 | 3 | CID000161214 | |
| Drug | hydantocidin | 1.01e-04 | 7 | 330 | 3 | CID000125429 | |
| Drug | 2',3'-dideoxy-3'-fluorocytidine | 1.01e-04 | 7 | 330 | 3 | CID000356019 | |
| Drug | heptenitol | 1.01e-04 | 7 | 330 | 3 | CID000188267 | |
| Drug | Promonta | 1.01e-04 | 7 | 330 | 3 | CID000108494 | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; PC3; HT_HG-U133A | DLG5 COCH NID1 PLCD1 DYNC2H1 GSAP DIS3 VCAN UBA6 QRSL1 TCTN2 | 1.14e-04 | 191 | 330 | 11 | 2055_DN |
| Disease | Intellectual Disability | HEXA TRIO INPP4A ZBTB24 PTCHD1 FASN SACS FDFT1 SCN1A SCN3A SCN8A TAF6 ALDH3A2 FBXW11 PUF60 GRIA2 TSEN54 PPP2R1A SUPT16H HTT | 1.06e-07 | 447 | 318 | 20 | C3714756 |
| Disease | Malignant neoplasm of breast | CD109 OBSCN DYSF GDF10 FSCB TXN FASN MIA2 H4C1 PLCB1 AP1M1 TIMELESS PLS3 MRE11 TBX3 DYNC2H1 B3GALNT2 LAMA2 SHMT1 MSI1 GRM6 MAP3K6 LEPR EPG5 CNNM4 PBRM1 SBNO1 ZNF277 MTR TOP2A SORL1 | 7.47e-07 | 1074 | 318 | 31 | C0006142 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.64e-06 | 10 | 318 | 4 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.64e-06 | 10 | 318 | 4 | DOID:0080422 (implicated_via_orthology) | |
| Disease | diet measurement | TDRD15 FAM184B LAYN TRIO C3orf38 UBAP1 DHDDS GDF10 TMCC3 DNAH14 SERPINI2 H4C1 SCN2A ANAPC4 MMS22L HTR1B SH3RF1 LAMA2 DIS3 LEPR SND1 INF2 KLHDC8A PCDHGB4 SMARCA2 RERE CDH13 EPHA7 SORL1 | 4.01e-06 | 1049 | 318 | 29 | EFO_0008111 |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 6.12e-06 | 12 | 318 | 4 | DOID:0060170 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | TDRD15 SARM1 HMGCR H4C1 ATXN2 FDFT1 PLCB3 CRPPA SPG11 TSEN54 PPARG TRIM5 HTT | 6.66e-06 | 264 | 318 | 13 | EFO_0008317, EFO_0020944 |
| Disease | Degenerative polyarthritis | 7.67e-06 | 93 | 318 | 8 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 7.67e-06 | 93 | 318 | 8 | C0086743 | |
| Disease | smoking status measurement | MON2 DLGAP1 ASIC2 MAP3K20 ABT1 DENND1B ATXN2 TGFBRAP1 SCN2A NUFIP2 RAB7A PLCL1 USH2A DNAH8 UTRN BTRC WDR24 MAPKAP1 PSAT1 MMS22L LAMA2 TRAP1 MCTP1 SYT14 KDM4A PLD5 RERE CRBN EPHA7 SORL1 | 9.97e-06 | 1160 | 318 | 30 | EFO_0006527 |
| Disease | Disorder of eye | CDHR1 DHDDS ADGRV1 BCOR SAG KLHL7 USH2A GRM6 CNNM4 VCAN TCTN2 | 2.10e-05 | 212 | 318 | 11 | C0015397 |
| Disease | growth/differentiation factor 5 measurement | 2.42e-05 | 6 | 318 | 3 | EFO_0020429 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 3.08e-05 | 56 | 318 | 6 | EFO_0022279 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | TDRD15 SARM1 HMGCR ATXN2 PLCB3 CRPPA SPG11 TSEN54 PPARG TRIM5 HTT | 3.22e-05 | 222 | 318 | 11 | EFO_0008317, EFO_0020943 |
| Disease | hypertension | ARHGAP42 SARM1 COL6A5 GDF10 ATXN2 PLCB3 BANK1 COL6A3 MKNK1 PBRM1 KDM4A CDH13 SOS2 | 3.27e-05 | 307 | 318 | 13 | EFO_0000537 |
| Disease | platelet crit | FAM184B PDE4A LRRK2 HMGCR ADGRV1 PDE10A S100A1 JAK2 BMP6 ATXN2 PLCB1 POLR1B ARHGAP25 WDR24 DIP2B TSEN54 PPARG LEPR EPG5 IGF2BP2 THOP1 SBNO1 PAK2 RERE SORL1 | 4.39e-05 | 952 | 318 | 25 | EFO_0007985 |
| Disease | puberty onset measurement | 6.58e-05 | 125 | 318 | 8 | EFO_0005677 | |
| Disease | muscular dystrophy (implicated_via_orthology) | 6.85e-05 | 21 | 318 | 4 | DOID:9884 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | 7.34e-05 | 163 | 318 | 9 | DOID:1826 (implicated_via_orthology) | |
| Disease | serum alanine aminotransferase measurement | DLGAP1 DLG5 MAP3K20 ALDH1L1 ATXN2 NUP210 DIP2B COL12A1 ANPEP SAMD4B SHMT1 PKD2L1 PPARG SERPINA6 LEPR TRIM5 CYFIP2 GSTM1 MLIP PCDHGB4 CDH6 HTT SOS2 | 7.92e-05 | 869 | 318 | 23 | EFO_0004735 |
| Disease | anxiety disorder (implicated_via_orthology) | 8.31e-05 | 22 | 318 | 4 | DOID:2030 (implicated_via_orthology) | |
| Disease | age at menarche | DLGAP1 C3orf38 GGT7 TGFBRAP1 SCN2A PDILT PLCB1 PLCL1 XYLB ANAPC4 HTR1B LEPR CYFIP2 IGF2BP2 SMARCA2 KDM4A RERE EPAS1 | 9.15e-05 | 594 | 318 | 18 | EFO_0004703 |
| Disease | Generalized Epilepsy with Febrile Seizures Plus | 9.93e-05 | 9 | 318 | 3 | C3502809 | |
| Disease | parental longevity | ARHGAP42 MAP3K20 PDE10A DENND1B H4C1 ATXN2 ANAPC4 MAPKAP1 PKD2L1 LMNB2 PPARG ZNF277 SMARCA2 CDH13 HTT EPHA7 | 1.05e-04 | 494 | 318 | 16 | EFO_0007796 |
| Disease | Neurotmesis | 1.16e-04 | 2 | 318 | 2 | C1142379 | |
| Disease | alkaline phosphatase measurement | TDRD15 DLG5 UBAP1 DHDDS DUS2 KIF9 SAG ATXN2 FDFT1 NUFIP2 PYGB PYGL ARHGAP25 PLCL1 UTRN ANAPC4 PKD2L1 TEAD1 PPARG TFAP4 LEPR TRIM5 MLIP RGS6 TCTN2 | 1.21e-04 | 1015 | 318 | 25 | EFO_0004533 |
| Disease | myocardial infarction | DAB2IP ARHGAP42 DHX36 TDRD15 CD109 HMGCR ATXN2 COL6A3 DYNC2H1 LMNB2 TRIM5 CDH13 HTT | 1.23e-04 | 350 | 318 | 13 | EFO_0000612 |
| Disease | sporadic amyotrophic lateral sclerosis | 1.45e-04 | 140 | 318 | 8 | EFO_0001357 | |
| Disease | cardiovascular disease | ARHGAP42 TDRD15 HMGCR PDE10A HOXC4 ATXN2 PDILT PLCB1 SIPA1L2 BANK1 NPR1 PKD2L1 AAGAB RERE SOS2 | 1.49e-04 | 457 | 318 | 15 | EFO_0000319 |
| Disease | Parkinson's disease (is_implicated_in) | 1.73e-04 | 76 | 318 | 6 | DOID:14330 (is_implicated_in) | |
| Disease | creatinine measurement | KIF21B INPP4A OBSCN ALDH1L1 ADGRV1 NEB GGT7 RAB24 FDFT1 PDILT XYLB ALDH3A2 DENND5B LAMA2 INTS8 MIPOL1 NAMPT MLIP SND1 PCDHGB4 EPAS1 CDH13 SORL1 SOS2 | 2.24e-04 | 995 | 318 | 24 | EFO_0004518 |
| Disease | Colorectal Carcinoma | CD109 OBSCN ALDH1L1 LPIN1 BMP6 FAT1 SACS PDILT NID1 DNAH8 ANAPC4 LMNB2 PPARG ERI2 GSTM1 NAMPT ABCA5 EPHA7 SORL1 | 2.50e-04 | 702 | 318 | 19 | C0009402 |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 2.90e-04 | 239 | 318 | 10 | EFO_0008317, EFO_0020945 | |
| Disease | Crohn's disease (is_implicated_in) | 2.91e-04 | 30 | 318 | 4 | DOID:8778 (is_implicated_in) | |
| Disease | IGF-1 measurement | PDE4A VPS13C DDX42 DHDDS PDE10A JAK2 FAM120A DENND5B TBX3 PPARG LEPR SBNO1 PLK4 TOP2A EPAS1 | 3.00e-04 | 488 | 318 | 15 | EFO_0004627 |
| Disease | C-reactive protein measurement | TDRD15 DCHS2 VPS13C CDHR3 DHDDS PDE10A TUFM KLHL7 FDFT1 NUFIP2 PYGB NID1 POLR1B BANK1 ANAPC4 MMS22L SPG11 SERPINA6 LEPR CYFIP2 ZNF3 DMC1 RGS6 SBNO1 AACS RERE EPHA7 | 3.01e-04 | 1206 | 318 | 27 | EFO_0004458 |
| Disease | testosterone measurement | FAM184B DLGAP1 DCHS2 PDE4A MYO5A C3orf38 ETF1 UBAP1 BMP6 FASN DENND1B TGFBRAP1 NUFIP2 PLCB1 USH2A UTRN BANK1 ARHGEF6 ANAPC4 DIP2B PPARG LEPR GSTM1 THOP1 RGS6 SMARCA2 EPAS1 SOS2 | 3.17e-04 | 1275 | 318 | 28 | EFO_0004908 |
| Disease | mean platelet volume | MYO5A KIF1B LRRK2 STK38 BCOR RAB8A JAK2 COCH ATXN2 PLCB1 NID1 BIN2 ALDH3A2 PLS3 BANK1 VAV1 PKD2L1 TFAP4 LEPR TRIM5 GSTM1 PCDHGB4 CATSPERB HTT | 3.22e-04 | 1020 | 318 | 24 | EFO_0004584 |
| Disease | Benign familial infantile epilepsy | 3.45e-04 | 3 | 318 | 2 | cv:C5575231 | |
| Disease | Microcephaly and chorioretinopathy | 3.45e-04 | 3 | 318 | 2 | cv:CN263236 | |
| Disease | Autosomal recessive chorioretinopathy-microcephaly syndrome | 3.45e-04 | 3 | 318 | 2 | cv:C3502492 | |
| Disease | polycystic kidney disease 2 (implicated_via_orthology) | 3.45e-04 | 3 | 318 | 2 | DOID:0110859 (implicated_via_orthology) | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 3.45e-04 | 3 | 318 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | polycythemia vera (is_implicated_in) | 3.45e-04 | 3 | 318 | 2 | DOID:8997 (is_implicated_in) | |
| Disease | Microcephaly with Chorioretinopathy, Autosomal Recessive | 3.45e-04 | 3 | 318 | 2 | C3502492 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | TDRD15 HMGCR ATXN2 PLCB3 BANK1 SPG11 TSEN54 LEPR TRIM5 GSTM1 HTT | 3.49e-04 | 291 | 318 | 11 | EFO_0008317, EFO_0020946 |
| Disease | smoking behavior | MAP3K20 ATXN2 POLR1B BTRC LAMA2 IGF2BP2 MCTP1 SYT14 KDM4A RERE EPHA7 SORL1 | 3.64e-04 | 341 | 318 | 12 | EFO_0004318 |
| Disease | schizophrenia, intelligence, self reported educational attainment | TGFBRAP1 PLCL1 BANK1 DENND5B MMS22L SH3RF1 TEAD1 RGS6 SLC25A12 SMARCA2 RERE CDH13 | 4.14e-04 | 346 | 318 | 12 | EFO_0004337, EFO_0004784, MONDO_0005090 |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | ASIC2 MAP3K20 DENND1B H4C1 ATXN2 SCN2A NUFIP2 RAB7A SIPA1L2 USH2A UTRN PSAT1 LAMA2 TEAD1 MCTP1 SND1 SYT14 CRBN CDH13 SORL1 | 4.85e-04 | 801 | 318 | 20 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | Calcium channel blocker use measurement | 5.40e-04 | 213 | 318 | 9 | EFO_0009930 | |
| Disease | Autistic Disorder | PDE4A ASIC2 PTCHD1 UBE3A HTR1B GSTM1 SLC25A12 SND1 PLD5 CDH9 | 5.79e-04 | 261 | 318 | 10 | C0004352 |
| Disease | Early infantile epileptic encephalopathy with suppression bursts | 6.26e-04 | 16 | 318 | 3 | C0393706 | |
| Disease | Ullrich congenital muscular dystrophy 1 | 6.85e-04 | 4 | 318 | 2 | C0410179 | |
| Disease | Dyggve-Melchior-Clausen disease (implicated_via_orthology) | 6.85e-04 | 4 | 318 | 2 | DOID:0111167 (implicated_via_orthology) | |
| Disease | Bethlem myopathy (is_implicated_in) | 6.85e-04 | 4 | 318 | 2 | DOID:0050663 (is_implicated_in) | |
| Disease | Ullrich congenital muscular dystrophy | 6.85e-04 | 4 | 318 | 2 | cv:C4551860 | |
| Disease | Bethlem myopathy | 6.85e-04 | 4 | 318 | 2 | cv:C1834674 | |
| Disease | BETHLEM MYOPATHY 1 | 6.85e-04 | 4 | 318 | 2 | C1834674 | |
| Disease | alcoholic cardiomyopathy (biomarker_via_orthology) | 6.85e-04 | 4 | 318 | 2 | DOID:12935 (biomarker_via_orthology) | |
| Disease | liver cancer (implicated_via_orthology) | 6.85e-04 | 4 | 318 | 2 | DOID:3571 (implicated_via_orthology) | |
| Disease | Ullrich congenital muscular dystrophy (is_implicated_in) | 6.85e-04 | 4 | 318 | 2 | DOID:0050558 (is_implicated_in) | |
| Disease | muscular dystrophy (is_implicated_in) | 7.54e-04 | 17 | 318 | 3 | DOID:9884 (is_implicated_in) | |
| Disease | ulcerative colitis (is_implicated_in) | 7.54e-04 | 17 | 318 | 3 | DOID:8577 (is_implicated_in) | |
| Disease | Familial Progressive Myoclonic Epilepsy | 7.54e-04 | 17 | 318 | 3 | C0751777 | |
| Disease | Atypical Inclusion-Body Disease | 7.54e-04 | 17 | 318 | 3 | C0751776 | |
| Disease | Myoclonic Epilepsies, Progressive | 7.54e-04 | 17 | 318 | 3 | C0751778 | |
| Disease | Biotin-Responsive Encephalopathy | 7.54e-04 | 17 | 318 | 3 | C0751780 | |
| Disease | May-White Syndrome | 7.54e-04 | 17 | 318 | 3 | C0751782 | |
| Disease | Dentatorubral-Pallidoluysian Atrophy | 7.54e-04 | 17 | 318 | 3 | C0751781 | |
| Disease | Adenoid Cystic Carcinoma | 7.62e-04 | 100 | 318 | 6 | C0010606 | |
| Disease | Parkinson disease | LRRK2 PTCHD1 KLHL7 FDFT1 SCN2A SIPA1L2 DNASE1L1 COL12A1 MIPOL1 RERE CDH13 | 7.88e-04 | 321 | 318 | 11 | MONDO_0005180 |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 7.98e-04 | 225 | 318 | 9 | EFO_0008317, EFO_0020947 | |
| Disease | Profound Mental Retardation | 8.02e-04 | 139 | 318 | 7 | C0020796 | |
| Disease | Mental deficiency | 8.02e-04 | 139 | 318 | 7 | C0917816 | |
| Disease | Mental Retardation, Psychosocial | 8.02e-04 | 139 | 318 | 7 | C0025363 | |
| Disease | DNA methylation | ARHGAP42 FAM184B DCHS2 SPAM1 TRIO GDF10 GRHL1 PLCB1 USH2A DNAH6 CRPPA TEAD1 TRIM5 IBTK TLR1 SMARCA2 CDH13 | 8.48e-04 | 656 | 318 | 17 | GO_0006306 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EITDIVFKIELYFQA | 1011 | Q8WWZ7 | |
| LFQYEREKTEGVVSI | 796 | Q5TYW2 | |
| YISVIQSIIFKDSED | 146 | Q8NDB2 | |
| QDVDVKYFAQEALTV | 571 | P30153 | |
| KQLFDYLIVIDFEST | 31 | A8K979 | |
| NYVLSEIEKNDVVFS | 341 | Q99814 | |
| AEFIQLYEQVVKFLS | 1741 | Q9HCE0 | |
| RVVDIYSKFDVINLA | 236 | P54619 | |
| YVNQVKVRVSDALLE | 286 | P28222 | |
| KYSVAEVFITLLDVN | 556 | Q96JP9 | |
| YYTVVLQNILDTEKE | 241 | Q15052 | |
| AQFYDDETVTVVLKD | 641 | Q9UJX5 | |
| LATAINEYNEIVERK | 426 | Q8IVF6 | |
| LFQYEREKAEGVVSI | 796 | Q5CZ79 | |
| YKLTLDSQVVQALFE | 636 | Q9H7T0 | |
| SFSLNVEYAIQAEKE | 1851 | P13611 | |
| EEELERTVHFYQKQV | 441 | Q8IX94 | |
| EEELERTVHFYQKQV | 441 | Q86UF2 | |
| EEELERTVHFYQKQV | 441 | P0CG41 | |
| EEELERTVHFYQKQV | 441 | A4FU28 | |
| EEELERTVHFYQKQV | 441 | A4D2H0 | |
| EIIYVAQEKLRNDTF | 1311 | Q68DQ2 | |
| QTKVEFPEARIYEET | 236 | Q13829 | |
| IVFSRVYDEVVDTSK | 71 | Q86V21 | |
| VITRIEIDTKYFEGN | 271 | Q8N6M5 | |
| QKFIEDNIEYITIIA | 36 | P43652 | |
| SEYAIRESNSIVKIF | 401 | P35606 | |
| LFQYEREKTEVVVSI | 796 | Q4UJ75 | |
| QEVKFELIVSEASYL | 1176 | Q12774 | |
| RAAVNVVDFDDKYIV | 426 | Q9Y297 | |
| EKEVYQVILYDVRTQ | 2781 | Q8WXG9 | |
| YRKNEVFLDVIESVN | 166 | Q9BXS5 | |
| VTTELEEYKEAFAVA | 896 | A2A2Z9 | |
| LTFDEYRNISQKDIV | 211 | P12429 | |
| KDRTFAVLAYSNVQE | 116 | Q96SW2 | |
| KSEFNVYSQEVITVL | 51 | P51648 | |
| FLEAYNTISEQAVKA | 236 | O14490 | |
| AFIVSEFDYVEKQAS | 281 | P15144 | |
| IIDNFDVYKVETIGD | 896 | P20594 | |
| IKAFVEQVANVVLYS | 241 | P10523 | |
| ELNGRYISNEFKVEV | 796 | O94985 | |
| VIDNFDVYKVETIGD | 911 | P16066 | |
| EVIAVYQLFVETTDV | 206 | P55290 | |
| SRLQKISEEYNVAVF | 251 | Q14565 | |
| VEIFRLVSKYQNEIS | 111 | Q9H7Y0 | |
| QAAAQELKAEYRVSV | 191 | Q9BZG8 | |
| NVEIVTIAEAEFYRQ | 1686 | Q6W2J9 | |
| EIYVAQFSEIKERIA | 126 | Q9UBW5 | |
| TVAFIQEYRSEKSLE | 146 | O75185 | |
| DIFFEALNYETIEQK | 406 | Q16515 | |
| QSDLFKAEYVLIVDS | 121 | Q5VWP3 | |
| NEVLYTTVNDEIFVL | 56 | O95199 | |
| LVYDITDEKSFENIQ | 86 | P51153 | |
| ILVYDITDEDSFQKV | 96 | Q9UL25 | |
| VDELFQKVAEDYVSV | 161 | Q969Q5 | |
| AYVVFKEESAATQAL | 246 | P42696 | |
| AIVVYDITNEESFAR | 96 | P20339 | |
| YFETSAKEAINVEQA | 151 | P51149 | |
| LVYDITNEKSFDNIR | 86 | P61006 | |
| KVAESLIAYTEQYVE | 281 | P49758 | |
| FEAVAITVKELVRYT | 811 | Q75QN2 | |
| FLTFAVERENVIEYK | 436 | O60674 | |
| YAAESIIKERISQEI | 271 | A4D126 | |
| SLVRLNSYFEQFKEV | 826 | Q96PE3 | |
| VLNTLDFEEVKEYSI | 301 | Q9UN71 | |
| QISVYSELNKIEVSF | 681 | Q9H8H0 | |
| LFQYEREKTEGVVSI | 796 | Q5SQ80 | |
| IEEVFEATDIKITVY | 136 | Q9Y530 | |
| FSNKVYVSDNIRIET | 376 | Q8TEM1 | |
| IFRENTLATKAIEEY | 411 | Q5VWQ8 | |
| FELDTLNKEYLVTVV | 2141 | Q14517 | |
| IYEDAVELQQFFIKI | 861 | Q86U86 | |
| VFLENVIRDAVTYTE | 61 | P62805 | |
| VIYLEIDVIFNAVKA | 736 | Q6DN14 | |
| IITEDLVQDKYVVYR | 331 | Q8N7X4 | |
| VDKEQQTYFSESEIV | 151 | Q5H9T9 | |
| YEEALKNRENIVSIT | 366 | Q8TD10 | |
| ASRVSSDVIDQKVYE | 76 | Q9Y262 | |
| YLYTDEAVVIKESQN | 826 | Q9P2D0 | |
| ILQLFKETNTDIYEV | 1096 | Q6ZRQ5 | |
| LLAVKYIFFEQTETE | 331 | P04035 | |
| TEVEFFDLNDTKLYV | 496 | O60303 | |
| NIAVEITESFVDYIK | 1171 | O60333 | |
| VYNVIRKQSEADLAE | 291 | Q6UX15 | |
| LVEVDSSRQQEYDFK | 241 | Q03252 | |
| QLDTRVSEFYEETKV | 136 | O95671 | |
| EEIESSAQYKARVAL | 446 | Q99700 | |
| TKVIYALNTRQDEAE | 46 | Q9ULE4 | |
| IVEEVKAQYDAVAAR | 251 | Q6KB66 | |
| EIFSDYTPAQVVVKE | 151 | Q96Q04 | |
| LKLQSVEYVVFDEAD | 236 | Q8TDD1 | |
| EFRNLAEKYQTVIAD | 131 | P37268 | |
| LEVVDQKAVYFFNLT | 106 | P55107 | |
| SIKTVINYDVARDID | 566 | Q86XP3 | |
| ALDAFYNADVVVLEV | 106 | O95382 | |
| QIVDYDDSLVSKFIE | 261 | P42262 | |
| EVLKNLATAYDNFVE | 651 | Q8WUM4 | |
| EFVYIFQEVKSSDIA | 76 | P13797 | |
| ITEEDFSNYSALVEK | 346 | Q9UJ14 | |
| DFLLDVSKTYFDNIV | 251 | Q9Y233 | |
| YISTTFLDKQNEVEI | 286 | P27815 | |
| ESFKEIVVTDYSDQN | 76 | P40261 | |
| DSVFVLYNQEEKILR | 636 | P14543 | |
| VNVVDFDDKYIVSAS | 366 | Q9UKB1 | |
| AYAILNRFEVEVTKE | 1146 | Q96JB1 | |
| KRTAQEAAVFLTLYE | 2281 | Q96JB1 | |
| FKVSAQFLELYNEEI | 141 | O75037 | |
| SIFSVVAYTIEKEEN | 341 | Q9ULS6 | |
| RFAVAALQSKVEQYE | 216 | Q5W0B1 | |
| EDSVSLAYQRVQKVD | 1721 | Q8TDM6 | |
| VSVFYDERIVVVAEQ | 851 | Q9P265 | |
| YQVEFEDGSQLVVKR | 986 | O75164 | |
| REITKDAFLEQAVSY | 476 | Q14693 | |
| LVSSLYRFKDVAEIQ | 631 | Q5S007 | |
| YTDLVAIQNKAEIEY | 61 | P14151 | |
| LSDDVVKATQAIYLF | 321 | Q6YN16 | |
| EVTYEDESQRQPFVK | 971 | P48357 | |
| VITEIKAQYDDIATR | 106 | A6NCN2 | |
| ISLVNKAAVDYFFVE | 1496 | Q96RT7 | |
| VVNVKTAVADNLLFY | 2171 | P24043 | |
| EQLVEFAYTARISVN | 96 | Q8IXQ5 | |
| VVVYVNKADAVQDSE | 176 | P49411 | |
| VNYVTAKDAERAINT | 66 | Q15717 | |
| VVIKAVADYVRNIQD | 281 | Q9NZB2 | |
| AVVNVTYATREEAKI | 121 | Q9Y6M1 | |
| QDLVYETVAKDVVSQ | 66 | Q9HAQ2 | |
| ERSLEVVVDLYQKTA | 1411 | Q7Z3U7 | |
| KVFAYINISVAEADL | 51 | Q76FK4 | |
| IVYFFSNLVLDDVKS | 276 | Q9Y5H7 | |
| NYTSEEKFAFVEVIA | 441 | Q96F07 | |
| DIIEYAELKTDVFQS | 1006 | Q96F07 | |
| VNYNFEDETVRKFLL | 611 | P29728 | |
| NLYVKIDTIAADESF | 141 | Q15375 | |
| EKQVTVLELFRVSSY | 276 | Q8TDB8 | |
| LSVNTTVEDVKQYFE | 116 | O43347 | |
| ERKVSASVAEVQEQY | 851 | Q27J81 | |
| RVQQIYSDSDLKVEV | 371 | Q86YT6 | |
| VEINIAVLYSFQSDK | 636 | P29475 | |
| AVLYSFQSDKVTIVD | 641 | P29475 | |
| DSSAYENVKFIVNVR | 121 | Q8IV76 | |
| TVIIKVYVTDVNDND | 2021 | Q6V1P9 | |
| EFEQAFYEVKIRENS | 241 | Q9Y5F2 | |
| ELNIQVDDSYARKIF | 171 | P51178 | |
| VYEDAQENFVLKILF | 286 | Q5VST9 | |
| AESVVVSTAIQEFYK | 5791 | Q5VST9 | |
| FTVEELKQRYDSVIN | 1321 | O94913 | |
| YRFAGKEIVIQESIE | 71 | Q5VZV1 | |
| EIYLVDVSEKTVEAF | 956 | Q460N5 | |
| QFLSDRKVGIYVEVD | 736 | Q01970 | |
| RLITFNEADESVNYK | 256 | Q6PI47 | |
| QAVLDVLKFYDSNTV | 121 | Q13177 | |
| TKLYQEVEIASVDAF | 826 | Q92900 | |
| VLLVEDSEKYEIFSQ | 146 | Q9BRQ4 | |
| EVVFELASYILQEAK | 136 | Q9P2Q2 | |
| QVFSYTANKEIRTDD | 466 | Q10472 | |
| AALKQVFEEANYEII | 1941 | Q8NCM8 | |
| VEAEAVYRAVTIAKQ | 231 | O14531 | |
| ISEEKYIEQFRIHVA | 171 | A4D1B5 | |
| AQAKRETDFYLQSVE | 176 | Q9ULW3 | |
| LFQYEREKTEGVVSI | 796 | Q5VUR7 | |
| ITAFYDSLKLVRAEQ | 1816 | Q13535 | |
| LEITIFNYLKDATEV | 766 | Q6YHK3 | |
| YRDQAAVIEAAKTVQ | 4026 | Q9C0G6 | |
| LKQFEYIEVGQFRES | 1476 | P42858 | |
| YKESFNTISNIEEIA | 341 | Q9NZI5 | |
| RDSTYEQEGKVQFVI | 391 | O15303 | |
| KELNALYDVFLEVSQ | 156 | P49184 | |
| IQVSFVQYSDEVKSE | 2361 | Q99715 | |
| FLNAYITVSEEVALK | 36 | Q9H0R6 | |
| QNKEVLELAFSILYD | 626 | Q96JJ3 | |
| VEKSVEEDYVTNIRN | 316 | Q8TBM8 | |
| FDLQIYVKDEVGVTD | 101 | Q6ZTQ4 | |
| KTTQVTQFILDNYIE | 236 | Q9H2U1 | |
| TVKLYQAEQEEALFI | 176 | Q8NCR0 | |
| VFVDVVDTYRNVPAK | 321 | Q8NCR0 | |
| VKFEQSDLEAFYNVI | 291 | Q5JPI3 | |
| VKTEFDFITYDNQLL | 2026 | A8TX70 | |
| AVAQYSDDVKVESRF | 876 | P12111 | |
| QEVLRFVSEIVDTVY | 1656 | P12111 | |
| INTSDAITDKDIVFY | 111 | P98187 | |
| QTSYDDLIRKVVEVF | 261 | P17707 | |
| TAYTRQQVLELEKEF | 161 | P09017 | |
| ISVLYFDDNSNVILK | 486 | P22004 | |
| EKVVAYFETTDQILD | 1156 | Q6ZUT9 | |
| ISDVQLEFTKLNIYF | 211 | P27544 | |
| VRIVEDYAQKTANEL | 2326 | Q0VDD8 | |
| FLKTEAYRLVQFETN | 171 | Q969Z3 | |
| DEIAITYIKDVTFNT | 466 | Q9NYL2 | |
| FSEYKELSAEVQAVL | 466 | Q8N4S9 | |
| DYVKVETEDQVLATF | 76 | P48740 | |
| TSYQLEELERAFQKT | 336 | Q96QS3 | |
| KYAVNAFEVFDIETR | 186 | Q8IYD2 | |
| IISKEDIRDNIVSYN | 646 | P55285 | |
| VDFELAVQNIVYRTA | 91 | Q9NYL5 | |
| QVLKFLSQDELVYTF | 311 | P38567 | |
| GIYQVKVEDAVVFST | 286 | Q86VF2 | |
| RLDDTYSFQVINKTV | 1336 | Q9H583 | |
| VELINKDYADFVNLS | 61 | Q14746 | |
| DRLFSSIVTVAEQKY | 396 | Q9NX74 | |
| SFAVVLYADFQERKI | 61 | Q5T890 | |
| FQKAVYQTVLETEDV | 406 | Q5T890 | |
| LYTLQDKAQVADVVV | 1066 | P49327 | |
| FTDYSTKENVLAVIR | 421 | O43405 | |
| ESRNLTEYFVAVDVN | 186 | Q6P3S1 | |
| LEVTVYAFSIENFKR | 71 | Q86SQ9 | |
| VLRSNEVAAEYFKNT | 71 | Q9UKG4 | |
| LDNNEIVATIKFTVY | 186 | Q9HBV2 | |
| FILVENAYVDSEKVS | 2346 | Q9NZJ4 | |
| VTFKIEEVLLSQSYV | 541 | A3KN83 | |
| KNFTLEQIVTYVADT | 781 | Q68D06 | |
| IISKDDVRDNIVTYN | 646 | Q9ULB4 | |
| TLKVYDTQLENVEAF | 1501 | O75923 | |
| TREENFYVDETTVVK | 216 | P08185 | |
| TSIKYNLEELYQAVE | 231 | Q13620 | |
| EKAYQVRDTAIESSV | 46 | P56373 | |
| RSQKATEFIDYSIEQ | 61 | Q9GZY1 | |
| EKFQSYEVNIEARDA | 311 | Q9UN66 | |
| EDASEFQILKYLFQI | 596 | Q96PC5 | |
| EVVEVFTDQATFYDK | 266 | Q9BUB5 | |
| KYQAAVQALREEVES | 456 | P34896 | |
| EDFKQLESFYIQTLL | 346 | P06865 | |
| DFVIEYNTENKDLIS | 256 | Q8N807 | |
| NIQFAIEYVESLKEL | 631 | Q9HCH5 | |
| LSVEQQLYYKEITEA | 216 | P49848 | |
| QADEKIVFTEYNTER | 4206 | O75445 | |
| SKDVVDYSEENFAIV | 216 | P21281 | |
| EKEYSVLNAVDQARV | 2611 | P46939 | |
| TVIVSKDEQYLFLVR | 1896 | Q92673 | |
| EEETQFYIAETVLAI | 186 | Q15208 | |
| IDLVDNYFVKDTSEA | 191 | Q9UPN9 | |
| VTFDYDSQEQKLLVT | 266 | Q8NB59 | |
| YSRLEVQADVQKEIF | 536 | Q6ZMZ0 | |
| EVYRFVVKDSEENIV | 571 | Q07890 | |
| TEFIAVTAYQNDKIT | 276 | O15119 | |
| SQIYEDSIVLQSVFK | 1486 | P51531 | |
| DFQEYVVLVAALTVA | 71 | P23297 | |
| LEIIFDVYQADAVAT | 446 | Q7Z6J9 | |
| IDAIYSVIDDAKQYV | 326 | Q8N7P1 | |
| DETLRLVQAFQYTDK | 226 | Q13162 | |
| KVVAEVYDQERFDNS | 541 | Q9UHX1 | |
| DTIKYIFNETEVIVF | 696 | Q4G0N8 | |
| QELASIEEKVAYQAY | 356 | Q9ULS5 | |
| LTQVSKEVDIVFVDY | 821 | B5MCY1 | |
| TYEQLVALENKFRAT | 171 | Q9UD57 | |
| DFIIAVKSDDQNYRV | 476 | A6NI28 | |
| EEIIEIFNTYSENRK | 71 | Q86YW0 | |
| VQEDVLEYTKGFVRI | 571 | Q96NR3 | |
| FDETYIENVVRNILK | 896 | Q8IVG5 | |
| NKITFVDFLVYDVLD | 151 | P09488 | |
| RSVEAVQEITEYAKS | 316 | P37231 | |
| YNAVTIEDVQKLAAF | 346 | Q9Y617 | |
| DQVEDYALRKNISVA | 1236 | Q99707 | |
| QEYLKDLAENFVTTA | 806 | Q9P2F8 | |
| AYIEFESIEAIVKTA | 746 | O15357 | |
| DAATVNEIVLKVNYI | 471 | Q9BPZ7 | |
| FLAEQDIVIITYDVL | 761 | Q149N8 | |
| EISYVFTSEKANQEE | 1486 | Q149N8 | |
| FYVQDVETGTQLEKL | 696 | Q7KZF4 | |
| EAEFNILLATDSYKV | 6 | P43490 | |
| AVVSIQDITVNYFKE | 291 | Q8TF30 | |
| YIAVILENFSVATEE | 1766 | Q9NY46 | |
| VIKNRELFISDYVDT | 221 | Q9P2R6 | |
| TLRVEDLVKQYFQTA | 426 | P49959 | |
| EYASQEYVKEVLQIS | 626 | O00444 | |
| EATFVKEITYRASNI | 591 | Q9Y5B9 | |
| VSEEAYILFVRKNAI | 846 | Q9Y2L1 | |
| YIAVILENFSVATEE | 1781 | P35498 | |
| ISVFKFNQELEYLDL | 86 | Q15399 | |
| ISYVEFNSAAKQLIE | 251 | Q7Z6J0 | |
| DLIVEVTSNDAVRFY | 31 | Q6PD74 | |
| EAALNEYLRVKTVTF | 886 | O75891 | |
| YEAAVEQLKSEQIRA | 96 | Q5T9A4 | |
| VEVTKEEFAQSAIRY | 246 | O75746 | |
| KEFLESVQRYIITET | 21 | Q8NHS4 | |
| SSVVNYEFEIALVLK | 156 | Q8N999 | |
| SDFSVRALVDLQYIK | 696 | Q6P4Q7 | |
| TEELIVQTKQVYDAV | 61 | Q9BYT8 | |
| SEKYSNVIFLEVDVD | 46 | P10599 | |
| NAKAVFIELADTVNY | 61 | Q96PV4 | |
| EDAQYSFIRESVAEK | 1286 | Q96JI7 | |
| IQKEDSFRILSYQVA | 386 | Q5SXH7 | |
| TEEVAREYQVKLQAA | 131 | Q9C035 | |
| NYFVTDSVTKQEIDL | 76 | Q5SV17 | |
| YLNFVTEEVENPEKT | 251 | Q9UPY5 | |
| VVQVSEKEFNFLDYL | 681 | Q9UNS1 | |
| EFYTKQDVIITALDN | 556 | A0AVT1 | |
| VIEVINKFAFVASEY | 471 | Q15111 | |
| FLVYEDRVQIVKEVS | 151 | Q8WUH2 | |
| KSQELVTFEDVAVYF | 46 | P17036 | |
| ETFQQLITYKVISNE | 341 | Q05086 | |
| LQVVREVQYDFSLEK | 46 | Q9NZ09 | |
| ALVFLSKDYEIESQN | 611 | Q7Z417 | |
| IALVQLAEEVSFTEY | 271 | Q86T26 | |
| QEYFVVAATLQDIIR | 296 | P11217 | |
| EYQEATIEKIIRFLQ | 686 | Q6SZW1 | |
| QKVLAYSIESNAFIE | 106 | Q5PRF9 | |
| STQATIDIYEKEEAF | 961 | Q8NDV3 | |
| VTAQEIDSYFRQELI | 286 | A6NFA1 | |
| VDYVDKVLETTVEIF | 366 | Q96QK1 | |
| FQRVYEIDITDASVV | 461 | Q9NW82 | |
| VFGQRLDETVAYEQK | 156 | P42331 | |
| DAAEFAISIKYNVEV | 701 | P15498 | |
| TELEKAVIVLVENFY | 6 | Q96FQ6 | |
| FLNDVKTLYETEVFS | 146 | P05543 | |
| VAKDNFEILVTFIYT | 271 | Q9NPI9 | |
| YIAVILENFSVATEE | 1771 | Q99250 | |
| KVVAVDAELNVFYEE | 21 | O75191 | |
| QEYFVVAATLQDIIR | 296 | P11216 | |
| VLNAIKRYQDVDSET | 216 | Q8IYQ7 | |
| YIAIILENFSVATEE | 1761 | Q9UQD0 | |
| VDFKDVLYSLNITEI | 296 | O75830 | |
| IDVSVITRFNEYSKV | 3241 | Q709C8 | |
| EIFKFEEQQRSLVYL | 141 | Q15166 | |
| FLAIINDTYSEVKAD | 486 | Q9NZM6 | |
| KVEFLVSFYNNEISE | 61 | A0A1B0GX68 | |
| SYIQEVVQYIKRLEE | 1101 | Q9NQ66 | |
| FLAIINDTYSEVKEE | 556 | Q9P0L9 | |
| TEQILATAQFLKVYD | 106 | O43167 | |
| VQDTFTYAKVVALIA | 191 | Q92536 | |
| VDYVADQIVTKLVDV | 326 | P11388 | |
| VIADVKLVADFQRYI | 86 | Q9NRM2 | |
| YSEKEVFIRELISNA | 106 | Q12931 | |
| LSLQKIIQFVETYAE | 366 | Q86YA3 | |
| ELKQDTTNADVYIFR | 196 | Q8NEE8 | |
| KYITVVVFEEEVILN | 71 | O43314 | |
| KQVVEKVETEYARFE | 331 | P28347 | |
| RSIFKIYAIEEEQFV | 46 | Q96S15 | |
| SEDAVQYFQRAVKDE | 501 | Q8N584 | |
| NNFEADAYFVKVIVL | 431 | Q8TB96 | |
| LVSFSDYQIFQELIK | 256 | Q9H9Y6 | |
| YLADTVQKLFANIAE | 31 | Q9NX45 | |
| KALADVEVTYTVQRN | 66 | P52888 | |
| QEYFVVAATLQDIIR | 296 | P06737 | |
| LEIQATKLEDSAVYF | 96 | A0A087WV62 | |
| FYFELDETERVNVNK | 411 | Q96QC0 | |
| QTAEYIFSLEQEKTR | 91 | Q01664 | |
| VIYEEATDLDKFITN | 351 | Q96GX1 | |
| SSELRTEVEENQKYF | 366 | Q9NYU2 | |
| IVSEYIDTFFEDLKQ | 2071 | O75962 | |
| YVRKVAETAVQLFIS | 201 | P62495 | |
| AVKLNELLENFYVTV | 451 | Q8N8K9 | |
| TYLLEKSRVVFQAEE | 241 | Q9Y4I1 | |
| YDAEVVAIAQKFAAL | 596 | Q6NSJ0 | |
| FTPVDDRVDYVTAKQ | 4156 | P20929 |